{ "company": "Thermo Fisher Scientific", "ticker": "TMO", "period": { "from": "2026-02-28", "to": "2026-03-30", "days": 30 }, "sentiment_breakdown": { "positive": 101, "negative": 54, "neutral": 70 }, "synthesis": { "executive_summary": "**Executive Summary: Thermo Fisher Scientific (TMO) Sentiment Analysis**\n\nDuring the period of February 28 to March 30, 2026, sentiment analysis for Thermo Fisher Scientific (TMO) indicated a net positive sentiment, with 101 positive mentions, 54 negative mentions, and 70 neutral mentions out of 225 total items. However, a review of the top sentiment-driving articles reveals a significant disconnect. The majority of highly positive articles were related to sports (rugby union results) and unrelated corporate acquisitions (e.g., Banzai's acquisition of ConnectAndSell), rather than TMO's direct operations or financial performance.\n\nSimilarly, the most significant negative sentiment drivers were predominantly general medical research articles on topics such as cancer progression and neurodegenerative disorders, or unrelated political commentary. No direct negative news impacting TMO's business, product pipeline, or market position was identified within the top negative items. This suggests that while the raw sentiment count is positive, the underlying data largely comprises irrelevant content, limiting its utility for assessing specific market perception or operational impact on Thermo Fisher Scientific.", "key_findings": [ "✓ Banzai Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities", "✓ Connacht secure bonus-point win over Ulster", "✓ Glasgow stretch lead in URC after Benetton win", "✗ Another Thing Trump and Epstein Share: White Supremacy", "✗ The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification", "✗ A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms" ], "overall_sentiment": "positive" }, "top_positive": [ { "title": "Banzai Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities", "date": "2026-03-23", "source": "news", "score": 1.0 }, { "title": "Connacht secure bonus-point win over Ulster", "date": "2026-03-20", "source": "news", "score": 0.944 }, { "title": "Glasgow stretch lead in URC after Benetton win", "date": "2026-03-27", "source": "news", "score": 0.934 }, { "title": "Big guns return as Leinster secure bonus-point win in United Rugby Championship over Scarlets", "date": "2026-03-27", "source": "news", "score": 0.898 }, { "title": "Ulster get back to winning ways against Zebre", "date": "2026-03-28", "source": "news", "score": 0.891 }, { "title": "Ulster get back to winning ways against Zebre", "date": "2026-03-28", "source": "news", "score": 0.891 }, { "title": "Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO", "date": "2026-03-29", "source": "alpha_vantage", "score": 0.865 }, { "title": "Oncology Clinical Trials Market Forecast 2026-2035 - AI Revolutionizes Oncology Clinical Trials: Boosts Recruitment, Optimizes Protocols", "date": "2026-03-23", "source": "news", "score": 0.84 }, { "title": "EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model", "date": "2026-03-20", "source": "news", "score": 0.84 }, { "title": "All Blacks Watch: Dave Rennie’s bench options on show in Super Rugby - Opinion", "date": "2026-03-23", "source": "news", "score": 0.832 } ], "top_negative": [ { "title": "Another Thing Trump and Epstein Share: White Supremacy", "date": "2026-03-18", "source": "news", "score": -0.904 }, { "title": "The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification", "date": "2026-03-24", "source": "news", "score": -0.893 }, { "title": "A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms", "date": "2026-03-24", "source": "news", "score": -0.881 }, { "title": "Assessment of references for the quantitative analysis of LINE-1 and Alu methylation in cellular DNA and circulating cell-free DNA of cancer patients", "date": "2026-03-23", "source": "news", "score": -0.869 }, { "title": "Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy", "date": "2026-03-24", "source": "news", "score": -0.829 }, { "title": "Faletau injured in Cardiff's defeat by Sharks", "date": "2026-03-27", "source": "news", "score": -0.807 }, { "title": "Shotgun metagenomic analysis of the oral microbiomes of children with noma", "date": "2026-03-20", "source": "news", "score": -0.784 }, { "title": "Intestinal barrier damage is associated with fine particulate matter (PM2.5)-induced pathological aortic injury in mice", "date": "2026-03-20", "source": "news", "score": -0.772 }, { "title": "Combined Nutritional and Exercise Interventions for Cachexia in Chronic Diseases: A Systematic Review and Meta-analysis Limited to Cancer Cachexia.", "date": "2026-03-30", "source": "pubmed", "score": -0.743 }, { "title": "Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.", "date": "2026 Mar 2", "source": "pubmed", "score": -0.67 } ], "raw_data": { "total_items": 225, "items": [ { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-03-24", "url": "https://www.sec.gov/Archives/edgar/data/97745/000009774526000066/0000097745-26-000066-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Food Testing Kits Market Is Going to Boom | Thermo Fisher Scientific • Eurofins Scientific • SGS SA", "url": "https://www.openpr.com/news/4445727/food-testing-kits-market-is-going-to-boom-thermo-fisher", "date": "2026-03-30", "summary": "A new report by Coherent Market Insights analyzes the Food Testing Kits Market, projecting substantial growth from 2026 to 2033. The report covers market trends, drivers, challenges, and the competitive landscape, highlighting key players, technological innovations, and investment potential. It provides a comprehensive segmentation including product types, applications, end-user markets, and geographical regions, aimed at empowering businesses with actionable insights for strategic decision-maki", "sentiment_score": 0.452929, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Wedge Capital Management L L P NC Sells 6,634 Shares of Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-wedge-capital-management-l-l-p-nc-sells-6634-shares-of-thermo-fisher-scientific-inc-tmo-2026-03-29/", "date": "2026-03-29", "summary": "Wedge Capital Management L L P NC has reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 35.2%, selling 6,634 shares and retaining 12,225 shares valued at $7.08 million. This comes as corporate insiders, including EVP Gianluca Pettiti and CEO Marc N. Casper, also sold shares, with insiders now owning approximately 0.33% of the stock. Despite these sales, analysts maintain a \"Moderate Buy\" consensus for TMO, with an average target price of $632.50, following the company's strong Q4 ", "sentiment_score": 0.256549, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.865, "confidence": 0.86 } }, { "source": "alpha_vantage", "title": "Canoe Financial LP Decreases Position in Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-canoe-financial-lp-decreases-position-in-thermo-fisher-scientific-inc-tmo-2026-03-29/", "date": "2026-03-29", "summary": "Canoe Financial LP significantly reduced its stake in Thermo Fisher Scientific Inc. by 91.9% in Q4, selling 8,268 shares and retaining 732 shares valued at approximately $424,000. Despite this decrease from one institutional investor, Thermo Fisher Scientific has garnered \"Moderate Buy\" ratings from analysts, with several increasing price targets to an average of $632.50. Furthermore, the company recently increased its quarterly dividend and reported strong Q4 earnings, surpassing analyst expect", "sentiment_score": 0.136768, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Assenagon Asset Management S.A. Has $6.22 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-assenagon-asset-management-sa-has-622-million-stock-holdings-in-thermo-fisher-scientific-inc-tmo-2026-03-29/", "date": "2026-03-29", "summary": "Assenagon Asset Management S.A. significantly reduced its stake in Thermo Fisher Scientific Inc. by 98.3% in Q4, now holding 10,740 shares valued at $6.223 million. Despite this, analysts maintain a \"Moderate Buy\" consensus with an average price target of $632.50. The article also notes recent insider selling by the CEO and EVP, alongside the company's recent dividend increase.", "sentiment_score": 0.249805, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.361, "confidence": 0.36 } }, { "source": "alpha_vantage", "title": "Revvity Vote On Special Meetings And Stock Retention Meets Valuation Gap", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-rvty/revvity/news/revvity-vote-on-special-meetings-and-stock-retention-meets-v", "date": "2026-03-28", "summary": "Revvity (NYSE:RVTY) is holding its annual meeting on April 28, 2026, where shareholders will vote on a bylaw change allowing holders of 25% of shares to call special meetings and on activist-backed proposals for executive stock retention. These votes, alongside the company's current valuation gap and recent stock decline, will determine the balance between board flexibility and shareholder influence. The article highlights that Revvity's shares are trading significantly below analyst targets and", "sentiment_score": 0.116477, "sentiment_label": "Neutral", "relevance_score": 0.617773, "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "alpha_vantage", "title": "Generate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-generate-investment-management-ltd-has-2066-million-stake-in-thermo-fisher-scientific-inc-tmo-2026-03-28/", "date": "2026-03-28", "summary": "Generate Investment Management Ltd significantly increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 131.4% in the fourth quarter of 2025, now holding 35,646 shares valued at $20.655 million. This comes as Thermo Fisher Scientific reported strong Q4 earnings, beating expectations, and raised its quarterly dividend, while analysts maintain a \"Moderate Buy\" rating with an average target price of $632.50. Despite institutional backing at 89.23%, some insider selling by executives has", "sentiment_score": 0.346854, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Is It Time To Revisit Bio-Techne (TECH) After Recent Share Price Weakness?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/is-it-time-to-revisit-bio-techne-tech-after-recent-share-pri", "date": "2026-03-28", "summary": "Bio-Techne (TECH) has experienced significant share price weakness, with declines over the past week, month, and year. Despite this, a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 29.1%. However, its current P/E ratio of 98.34x is considerably higher than the industry average and Simply Wall St's Fair Ratio, indicating it is overvalued on that metric.", "sentiment_score": 0.13398, "sentiment_label": "Neutral", "relevance_score": 0.648607, "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC", "url": "https://nationaltoday.com/us/ny/new-york/news/2026/03/28/thermo-fisher-scientific-shares-sold-by-davenport-co-llc/", "date": "2026-03-28", "summary": "DAVENPORT & Co LLC significantly reduced its stake in Thermo Fisher Scientific Inc. by 87.3% during the fourth quarter, selling 34,817 shares. The investment management firm now holds 5,070 shares valued at $2.94 million. This move reflects broader market trends and investor sentiment, though the institutional investor retains a holding, indicating continued long-term confidence.", "sentiment_score": -0.25292, "sentiment_label": "Somewhat-Bearish", "relevance_score": 0.957181, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Eagle Rock Investment Company LLC Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-eagle-rock-investment-company-llc-boosts-stock-position-in-thermo-fisher-scientific-inc-tmo-2026-03-28/", "date": "2026-03-28", "summary": "Eagle Rock Investment Company LLC significantly increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 15.9% in the fourth quarter, making the stock its 16th largest position. Other institutional investors also adjusted their holdings, while company insiders made notable stock sales. Analysts generally maintain a \"Moderate Buy\" rating for Thermo Fisher Scientific, which recently increased its quarterly dividend.", "sentiment_score": 0.383981, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of \"Moderate Buy\" from Analysts", "url": "https://www.marketbeat.com/instant-alerts/thermo-fisher-scientific-inc-nysetmo-receives-consensus-rating-of-moderate-buy-from-analysts-2026-03-28/", "date": "2026-03-28", "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) has received a \"Moderate Buy\" consensus rating from twenty-two research firms, with most analysts issuing buy recommendations and an average 12-month target price of $632.50. The company recently reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend. Insider activity shows some selling by executives, while institutional investors have significantly increased their positions in the company.", "sentiment_score": 0.459494, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Qiagen N.V. Stock: Steady Position in Molecular Diagnostics Amid Sector Growth Opportunities", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/qiagen-n-v-stock-steady-position-in-molecular-diagnostics-amid-sector/69007382", "date": "2026-03-27", "summary": "Qiagen N.V. (QGEN) maintains a stable position in the molecular diagnostics and life sciences sector, providing essential sample and assay technologies for various applications. The company's diversified business model, global footprint, and focus on high-growth areas like next-generation sequencing and human identification make it an attractive consideration for North American investors seeking exposure to the biotech tools space. While facing competition and regulatory risks, Qiagen's consiste", "sentiment_score": 0.342305, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.636467, "sentiment": { "label": "positive", "score": 0.637, "confidence": 0.64 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc Stock (TMO) Moved Down by 3.31% on Mar 27: What Investors Need To Know", "url": "https://www.tradingkey.com/news/Market-Movers/261729372-market-movers-tmo-20260327", "date": "2026-03-27", "summary": "Thermo Fisher Scientific (TMO) stock dropped 3.31% due to several factors, including margin pressures, cautious 2026 guidance, and integration risks from its recent acquisition of Clario Holdings. The decline was also influenced by broader market sentiment, insider sales, and an institutional adjustment by Vanguard. Despite these pressures, analysts largely maintain a \"Moderate Buy\" rating for the stock.", "sentiment_score": -0.431378, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Vanguard Amends 13G: Reports 0 Shares in Thermo Fisher (TMO)", "url": "https://www.stocktitan.net/sec-filings/TMO/schedule-13g-a-thermo-fisher-scientific-inc-amended-passive-investmen-f56247a52561.html", "date": "2026-03-27", "summary": "Vanguard Group has filed an amendment to its Schedule 13G/A, reporting 0 shares and 0% beneficial ownership in Thermo Fisher Scientific Inc. This change follows an internal realignment effective January 12, 2026, which disaggregated reporting responsibilities among Vanguard's subsidiaries and business divisions. The amendment clarifies that while Vanguard Group itself no longer directly reports ownership, its disaggregated entities continue to pursue similar investment strategies.", "sentiment_score": 0.002515, "sentiment_label": "Neutral", "relevance_score": 0.305932, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Q4 Rundown: Sotera Health Company (NASDAQ:SHC) Vs Other Research Tools & Consumables Stocks", "url": "https://www.theglobeandmail.com/investing/markets/stocks/SHC/pressreleases/999492/q4-rundown-sotera-health-company-nasdaqshc-vs-other-research-tools-consumables-stocks/", "date": "2026-03-27", "summary": "This article provides a Q4 rundown of Sotera Health Company (NASDAQ:SHC) and other research tools & consumables stocks, highlighting their financial performance and market reception. Sotera Health exceeded analysts' expectations with strong revenues and a positive outlook, despite a subsequent stock dip. The article also reviews top performers like Bio-Techne and notes the weakest, Mettler-Toledo, while touching on broader market shifts driven by AI and geopolitical events.", "sentiment_score": 0.236377, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.718453, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "There's A Lot To Like About Agilent Technologies' (NYSE:A) Upcoming US$0.255 Dividend", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/theres-a-lot-to-like-about-agilent-technologies-nysea-upcomi", "date": "2026-03-27", "summary": "Agilent Technologies (NYSE:A) is set to pay a US$0.255 dividend, offering a trailing yield of 0.9%. The company demonstrates strong dividend sustainability with a low payout ratio of 22% of income and 28% of free cash flow, alongside robust earnings per share growth of 14% annually over the last five years. These factors, combined with a decade of consistent dividend growth, suggest an attractive investment for dividend-focused shareholders.", "sentiment_score": 0.046516, "sentiment_label": "Neutral", "relevance_score": 0.612411, "sentiment": { "label": "positive", "score": 0.361, "confidence": 0.36 } }, { "source": "alpha_vantage", "title": "Agilent Technologies Inc. stock: Precision instruments leader navigating life sciences and diagnosti", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-inc-stock-precision-instruments-leader-navigating/69004318", "date": "2026-03-27", "summary": "Agilent Technologies Inc. is a leader in precision instrumentation for life sciences, diagnostics, and applied chemical markets, providing critical tools for pharmaceuticals, biotech, and environmental testing. The company's business model is diversified across three primary segments, focusing on innovation, global expansion, and a strong competitive moat. It offers North American investors exposure to high-growth areas within healthcare, balanced by recurring revenues and a commitment to capita", "sentiment_score": 0.103296, "sentiment_label": "Neutral", "relevance_score": 0.734559, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release", "url": "https://www.barchart.com/story/news/1000546/what-you-need-to-know-ahead-of-thermo-fisher-scientific-s-earnings-release", "date": "2026-03-27", "summary": "Thermo Fisher Scientific Inc. (TMO) is set to release its fiscal first-quarter earnings for 2026, with analysts expecting a 3.1% increase in EPS to $5.31. Despite consistently beating EPS estimates, TMO's stock has underperformed the S&P 500 over the past year. Analysts hold a \"Strong Buy\" rating for TMO, with a significant potential upside of 36.1% from current levels.", "sentiment_score": 0.381011, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Waters Corp Stock: Analytical Instruments Leader Faces Growth Challenges Amid Sector Tailwinds", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/waters-corp-stock-analytical-instruments-leader-faces-growth-challenges/69003163", "date": "2026-03-27", "summary": "Waters Corp (NYSE:WAT), a leader in analytical workflow solutions, faces growth challenges despite tailwinds in the scientific instruments sector. The company specializes in liquid chromatography and mass spectrometry, serving pharmaceutical, biotech, and environmental testing markets. While institutional investors like Vanguard maintain positions, recent performance has been mixed, with modest share declines and analyst ratings leaning towards a \"Moderate Buy.\"", "sentiment_score": 0.116626, "sentiment_label": "Neutral", "relevance_score": 0.640323, "sentiment": { "label": "positive", "score": 0.44, "confidence": 0.44 } }, { "source": "alpha_vantage", "title": "Thermo Fisher and SHL Medical collaborate to deliver fully integrated drug-device solutions", "url": "https://www.biospectrumasia.com/news/27/27412/thermo-fisher-and-shl-medical-collaborate-to-deliver-fully-integrated-drug-device-solutions.html", "date": "2026-03-27", "summary": "Thermo Fisher Scientific has announced a strategic collaboration with SHL Medical and an expansion at its Ridgefield, NJ site to offer fully integrated drug-device solutions in the US. This initiative combines sterile manufacturing, device assembly, and commercial packaging, addressing the growing demand for patient-centric, self-administered injectable therapies. The partnership integrates SHL Medical's Molly® autoinjector platform with Thermo Fisher's capabilities, aiming to simplify developme", "sentiment_score": 0.420121, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.241, "confidence": 0.24 } }, { "source": "alpha_vantage", "title": "Whole Genome Sequencing Market Key Aspects, Benefits, and Challenges 2026-2033 | Major Companies - Illumina; Inc., QIAGEN, Agilent Technologies, PerkinElmer Genomics", "url": "https://www.openpr.com/news/4442890/whole-genome-sequencing-market-key-aspects-benefits", "date": "2026-03-27", "summary": "The global Whole Genome Sequencing (WGS) Market is projected to grow at a CAGR of 15% from 2024 to 2031, driven by rising demand for precision medicine, technological advancements, and decreasing costs. Key players include Illumina, Thermo Fisher Scientific, QIAGEN, and Agilent Technologies, with significant recent developments in the U.S. and Japan focusing on AI integration and expanded clinical adoption. The market covers instruments, consumables, and services across diagnostics, drug discove", "sentiment_score": 0.304315, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.608147, "sentiment": { "label": "positive", "score": 0.44, "confidence": 0.44 } }, { "source": "alpha_vantage", "title": "Plus Therapeutics, Inc. Announces Appointment of Ron Andrews to Its Board of Directors", "url": "https://www.marketscreener.com/news/plus-therapeutics-inc-announces-appointment-of-ron-andrews-to-its-board-of-directors-ce7e51dbdf88ff23", "date": "2026-03-27", "summary": "Plus Therapeutics, Inc. has announced the appointment of Ron Andrews, a veteran in the diagnostics industry, to its Board of Directors. Andrews brings over 35 years of experience leading organizations in diagnostics and molecular diagnostics, including roles at Abbott Diagnostics, Roche Molecular Diagnostics, and several start-up companies. His expertise encompasses product development, fundraising, and significant capitalization events, making him a valuable addition to Plus Therapeutics' leade", "sentiment_score": 0.148985, "sentiment_label": "Neutral", "relevance_score": 0.609426, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Is Thermo Fisher Scientific (TMO) One of the Best Conservative Stocks to Buy Right Now?", "url": "https://www.insidermonkey.com/blog/is-thermo-fisher-scientific-tmo-one-of-the-best-conservative-stocks-to-buy-right-now-1725414/?amp=1", "date": "2026-03-27", "summary": "Thermo Fisher Scientific (TMO) is highlighted as a conservative stock to consider after its acquisition of Clario Holdings, Inc., which is expected to contribute significantly to its biopharma services segment with attractive financial profiles and synergy realizations. The article mentions TMO's extensive product and service offerings in pharmaceuticals and biotechnology. It also includes a promotional section for an AI stock, suggesting it has greater upside potential than TMO.", "sentiment_score": 0.326907, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.977438, "sentiment": { "label": "positive", "score": 0.637, "confidence": 0.64 } }, { "source": "alpha_vantage", "title": "Stoke Therapeutics (NASDAQ:STOK) Sees Unusually-High Trading Volume - Still a Buy?", "url": "https://www.marketbeat.com/instant-alerts/stoke-therapeutics-nasdaqstok-sees-unusually-high-trading-volume-still-a-buy-2026-03-26/", "date": "2026-03-26", "summary": "Stoke Therapeutics (NASDAQ:STOK) experienced an unusually high trading volume, with shares increasing 240% from the previous session. Despite notable insider selling, analysts maintain a \"Moderate Buy\" consensus with an average price target of $41.83, some as high as $60. The company, focused on genetic medicines for rare disorders, also saw significant institutional investment in the last quarter.", "sentiment_score": 0.318122, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.634551, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Is It Time To Reassess Thermo Fisher Scientific (TMO) After Recent Share Price Weakness?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/is-it-time-to-reassess-thermo-fisher-scientific-tmo-after-re", "date": "2026-03-26", "summary": "This article reassesses Thermo Fisher Scientific (TMO) following recent share price weakness. Using a Discounted Cash Flow analysis, the stock is estimated to be roughly 4.3% undervalued, while its P/E ratio suggests it is undervalued compared to industry and peer averages. The article encourages investors to use Simply Wall St's \"Narratives\" feature to align valuation with their personal investment outlook.", "sentiment_score": 0.26625, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "alpha_vantage", "title": "ELVN Stock Soars as Merck’s Billion-Dollar Acquisition Validates Strategy", "url": "https://www.timothysykes.com/news/enliven-therapeutics-inc-elvn-news-2026_03_26/", "date": "2026-03-26", "summary": "Enliven Therapeutics Inc. (ELVN) stock surged by 13.99% following promising developments and FDA designations for its ELVN-001 candidate. The market's positive reaction is further fueled by Merck's acquisition of Terns Pharmaceuticals, which validates the chronic myeloid leukemia market and highlights the potential of Enliven's drug. Despite a recent quarterly loss, Enliven maintains a strong cash position, and analysts like Mizuho have raised price targets, indicating confidence in its growth p", "sentiment_score": 0.324462, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.612036, "sentiment": { "label": "positive", "score": 0.54, "confidence": 0.54 } }, { "source": "alpha_vantage", "title": "Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now?", "url": "https://www.msn.com/en-us/money/markets/is-thermo-fisher-scientific-tmo-one-of-the-best-conservative-stocks-to-buy-right-now/ar-AA1ZtssQ?ocid=finance-verthp-feeds", "date": "2026-03-26", "summary": "This article evaluates Thermo Fisher Scientific (TMO) as a potential conservative stock investment. It aims to determine if TMO's financial performance and market position make it an attractive option for investors seeking stability.", "sentiment_score": 0.345448, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.637, "confidence": 0.64 } }, { "source": "alpha_vantage", "title": "Qiagen N.V. Stock: A Core Player in Molecular Diagnostics for Long-Term Investor Focus", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/qiagen-n-v-stock-a-core-player-in-molecular-diagnostics-for-long-term/68995799", "date": "2026-03-26", "summary": "Qiagen N.V. (ISIN: NL0012169213) is highlighted as a leading molecular diagnostics and life sciences tools company, offering sample-to-insight solutions across genomics, diagnostics, and pharma research. The article details its business model, core operations emphasizing recurring revenue from consumables, and strong market position in areas like next-generation sequencing and point-of-care testing. It also addresses the company's relevance for North American investors, competitive advantages, a", "sentiment_score": 0.229076, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.621984, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Ronald Andrews joins Plus Therapeutics (NASDAQ: PSTV) board", "url": "https://www.stocktitan.net/sec-filings/PSTV/8-k-plus-therapeutics-inc-reports-material-event-fb950f1b8d69.html", "date": "2026-03-26", "summary": "Plus Therapeutics (NASDAQ: PSTV) announced the appointment of Ronald A. Andrews to its board of directors, effective March 20, 2026. Andrews will fill the vacancy left by Dr. Robert Lenk's resignation and will also serve on the Nominating and Corporate Governance Committee, qualifying as an independent director under Nasdaq rules. He brings over 35 years of leadership experience in diagnostics and molecular diagnostics, including previous CEO roles and multiple board positions.", "sentiment_score": 0.117393, "sentiment_label": "Neutral", "relevance_score": 0.642522, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Veteran tied to $15B in exits joins Plus Therapeutics board", "url": "https://www.stocktitan.net/news/PSTV/plus-therapeutics-appoints-diagnostics-and-molecular-diagnostics-x9l3y8uq7ics.html", "date": "2026-03-26", "summary": "Plus Therapeutics (Nasdaq: PSTV) has appointed diagnostics industry veteran Ron Andrews to its Board of Directors. Andrews brings over 35 years of experience from companies like Abbott, Roche, and Thermo Fisher, and has been involved in over $600 million in capitalization and approximately $15 billion in exits. He will play a key role in scaling CNSide, a cerebrospinal-fluid diagnostic for leptomeningeal metastases, and advise on strategy, fundraising, and commercialization for the company's dia", "sentiment_score": 0.116658, "sentiment_label": "Neutral", "relevance_score": 0.61549, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Agilent Technologies Inc. stock climbs on launch of advanced chromatography solutions boosting life sciences research", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-inc-stock-climbs-on-launch-of-advanced/68993869", "date": "2026-03-26", "summary": "Agilent Technologies Inc. (US00846U1016) stock has risen following the launch of new chromatography solutions designed to accelerate life sciences research and drug discovery. The company's innovations address key challenges in biotechnology R&D, positioning Agilent as a leader in analytical instrumentation and attracting investor interest. This development comes amid renewed investor appetite for life sciences enablers and aims to expand Agilent's market share in high-growth areas.", "sentiment_score": 0.294905, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.698745, "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "alpha_vantage", "title": "Revvity Inc. stock faces pressure amid life sciences sector slowdown as Q4 earnings loom", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/revvity-inc-stock-faces-pressure-amid-life-sciences-sector-slowdown-as-q4/68989833", "date": "2026-03-26", "summary": "Revvity Inc. is facing pressure due to a slowdown in the life sciences sector, marked by reduced research funding and biopharma spending cuts, which led to flat Q4 revenue and organic declines. US investors should monitor the upcoming Q4 results for insights into NIH funding impacts, biopharma R&D recovery, and the integration of acquisitions like BioLegend, especially given the company's significant US customer base and the resilience of its diagnostics segment. Despite sector headwinds, the co", "sentiment_score": -0.111968, "sentiment_label": "Neutral", "relevance_score": 0.667401, "sentiment": { "label": "negative", "score": -0.477, "confidence": 0.48 } }, { "source": "alpha_vantage", "title": "Agilent Technologies Inc. stock climbs amid new chromatography solutions launch signaling life sciences expansion", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/agilent-technologies-inc-stock-climbs-amid-new-chromatography-solutions/68989819", "date": "2026-03-26", "summary": "Agilent Technologies Inc. (NYSE: A) stock rose after the company launched new chromatography solutions, enhancing its offerings for the life sciences sector. These advanced tools, designed for complex biomolecule analysis, are expected to accelerate drug discovery and boost Agilent's market share in biopharma and diagnostics. The move aligns with growing demand for precise analytical instruments and is seen as a strategic push into high-growth markets, attracting investor confidence.", "sentiment_score": 0.113161, "sentiment_label": "Neutral", "relevance_score": 0.609567, "sentiment": { "label": "positive", "score": 0.178, "confidence": 0.18 } }, { "source": "alpha_vantage", "title": "Illumina Inc. stock navigates Grail divestiture challenges amid biotech sector pressures", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/illumina-inc-stock-navigates-grail-divestiture-challenges-amid-biotech/68989172", "date": "2026-03-26", "summary": "Illumina Inc. (ISIN: US4523271090) is facing market pressures due to the divestiture of its cancer detection subsidiary, Grail, and broader biotech sector challenges. The company's stock is impacted by regulatory scrutiny over the Grail acquisition, ongoing legal battles, and a softening biotech market with reduced funding and increased competition. Despite these headwinds, Illumina maintains a strong balance sheet and is focusing on core genomic sequencing platforms and pipeline innovations to ", "sentiment_score": 0.111256, "sentiment_label": "Neutral", "relevance_score": 0.604197, "sentiment": { "label": "negative", "score": -0.25, "confidence": 0.25 } }, { "source": "alpha_vantage", "title": "List of 55 Acquisitions by Thermo Fisher Scientific (Mar 2026)", "url": "https://tracxn.com/d/acquisitions/acquisitions-by-thermo-fisher-scientific/__3TRGFxUu5eCJoMITE-e61ZEC_LKnhkY6JUsM7B5inds", "date": "2026-03-26", "summary": "This article details Thermo Fisher Scientific's 55 acquisitions, highlighting their most active years in 2017 and 2021 with five acquisitions each. The company's recent acquisition was Clario for $9 billion in November 2025, a CRO in the biopharma sector. Thermo Fisher Scientific primarily focuses on Life Sciences Platforms and Tools and Genomics sectors, with significant activity in the United States.", "sentiment_score": 0.334591, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Danaher Corp. stock faces pressure amid life sciences slowdown and market shifts", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-corp-stock-faces-pressure-amid-life-sciences-slowdown-and-market/68988866", "date": "2026-03-26", "summary": "Danaher Corp. (ISIN: US2358511028) is experiencing stock pressure due to a slowdown in its life sciences division, a critical revenue component. The segment faces reduced demand post-pandemic and tighter biotech funding, prompting Danaher to strategically divest non-core assets and focus on higher-growth areas through its \"Danaher Business System.\" Despite these challenges, the company maintains robust free cash flow and a strong balance sheet, positioning it for potential recovery and opportuni", "sentiment_score": 0.103932, "sentiment_label": "Neutral", "relevance_score": 0.665675, "sentiment": { "label": "negative", "score": -0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors", "url": "https://www.bitget.com/asia/news/detail/12560605306690", "date": "2026-03-26", "summary": "Plus Therapeutics, a healthcare company focused on CNS cancers, has appointed Ron Andrews, a diagnostics industry veteran, to its Board of Directors. Andrews brings over 35 years of experience in diagnostics and molecular diagnostics, with a strong background in scaling organizations and securing capital. His expertise is expected to significantly benefit the company, particularly in the global expansion of its CNSide diagnostic platform.", "sentiment_score": 0.206787, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.623273, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year", "url": "https://www.marketbeat.com/instant-alerts/nautilus-biotechnology-unveils-voyager-proteomics-platform-targets-beta-access-in-2h-and-launch-next-year-2026-03-25/", "date": "2026-03-25", "summary": "Nautilus Biotechnology (NASDAQ: NAUT) has revealed its new Voyager proteomics platform, which aims to provide high-resolution, single-molecule protein analysis to improve drug development and diagnostics. The benchtop instrument is expected to be priced around $1 million, with beta access targeted for the second half of the year and general availability in 2027. The company projects the proteomics market to reach $57 billion by 2030 and has sufficient cash runway through 2027 to support its laun", "sentiment_score": 0.137459, "sentiment_label": "Neutral", "relevance_score": 0.747708, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/is-it-time-to-reassess-danaher-dhr-after-recent-share-price-1", "date": "2026-03-25", "summary": "Danaher (DHR) shares have experienced a recent decline, prompting a reassessment of its valuation. While a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 16.7% with an intrinsic value of $224.64 per share, its current P/E ratio of 36.76x is above the industry average, indicating it might be overvalued based on earnings comparisons. Investors can use Simply Wall St's \"Narratives\" feature to apply their own future forecasts to the company's valuation.", "sentiment_score": 0.132935, "sentiment_label": "Neutral", "relevance_score": 0.646366, "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "alpha_vantage", "title": "Guardant Health Ignites 5.6% Surge: A Volatile Breakout or a Trap for the Unwary?", "url": "https://www.bitget.com/news/detail/12560605304566", "date": "2026-03-25", "summary": "Guardant Health (GH) experienced a 5.63% intraday surge to $89.245, driven by a new partnership with Manulife, despite technical indicators like the RSI being deeply oversold. While the rally shows short-term bullish momentum and potential for breakout past the 30-day moving average, it faces resistance around the $90 psychological barrier and requires sustained movement above $95 to confirm a trend reversal. Options traders are targeting calls with high leverage and liquidity, signaling aggress", "sentiment_score": 0.006873, "sentiment_label": "Neutral", "relevance_score": 0.621474, "sentiment": { "label": "negative", "score": -0.318, "confidence": 0.32 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio", "url": "https://www.pharmiweb.com/press-release/2026-03-25/thermo-fisher-scientific-and-shl-medical-collaborate-to-deliver-fully-integrated-drug-device-solutio", "date": "2026-03-25", "summary": "Thermo Fisher Scientific and SHL Medical have announced a strategic collaboration to provide fully integrated drug-device solutions. This partnership, combined with an expansion at Thermo Fisher's Ridgefield, NJ site, will offer sterile manufacturing, device assembly, and commercial packaging for drug-device combination products in a single U.S. location. The initiative aims to streamline supply chains and accelerate the delivery of self-administered injectable therapies to patients.", "sentiment_score": 0.032412, "sentiment_label": "Neutral", "relevance_score": 0.33572, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions", "url": "https://www.biospace.com/press-releases/thermo-fisher-scientific-and-shl-medical-collaborate-to-deliver-fully-integrated-drug-device-solutions", "date": "2026-03-25", "summary": "Thermo Fisher Scientific has announced a strategic collaboration with SHL Medical and an expansion of its Ridgefield, NJ facility. This partnership aims to provide fully integrated drug-device solutions in the U.S., combining sterile fill-finish, device final assembly, and commercial packaging for drug-device combination products. The initiative seeks to streamline supply chains and accelerate the delivery of therapies, especially for self-administered injectable treatments.", "sentiment_score": 0.012201, "sentiment_label": "Neutral", "relevance_score": 0.314829, "sentiment": { "label": "positive", "score": 0.241, "confidence": 0.24 } }, { "source": "alpha_vantage", "title": "Thermo Fisher completes $8.9B buyout of Clario", "url": "https://www.medtechdive.com/news/thermo-fisher-completes-89b-buyout-of-clario/815638/", "date": "2026-03-25", "summary": "Thermo Fisher Scientific has finalized its $8.9 billion acquisition of Clario, enhancing its capabilities in clinical trial endpoint data management. By integrating Clario's data capture and interpretation technology with its existing biological sample analysis, Thermo Fisher aims to create a unified, high-growth solution for drug developers. The deal, which includes potential earn-out payments, received approval from the European Commission with minimal competition concerns and is part of Therm", "sentiment_score": 0.403736, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Registry", "url": "https://www.contractpharma.com/breaking-news/thermo-fisher-scientific-launches-ppd-corevitas-alzheimers-registry/", "date": "2026-03-25", "summary": "Thermo Fisher Scientific has launched the PPD CorEvitas Alzheimer’s Disease Registry, an international and multi-country initiative aimed at generating real-world data to evaluate drug safety and effectiveness. The registry, which has already enrolled its first patient, will provide a comprehensive understanding of Alzheimer's therapy outcomes, long-term safety, and treatment patterns from routine clinical practice. This effort will help inform regulators, clinicians, patients, and caregivers by", "sentiment_score": 0.424651, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Haemonetics Corp stock faces uncertainty amid lack of fresh catalysts in blood management sector", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/haemonetics-corp-stock-faces-uncertainty-amid-lack-of-fresh-catalysts-in/68984630", "date": "2026-03-25", "summary": "Haemonetics Corp stock is currently in a holding pattern due to a lack of fresh catalysts in the blood management sector, despite steady demand for its plasma collection and transfusion technologies. The company, a leader in automated blood processing, benefits from recurring disposable sales in its Plasma and Blood Center segments. Investors should consider the company's solid financial health and", "sentiment_score": 0.114009, "sentiment_label": "Neutral", "relevance_score": 0.642006, "sentiment": { "label": "negative", "score": -0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific acquires Clario for nearly $8.9bn", "url": "https://www.clinicaltrialsarena.com/news/thermo-fisher-scientific-acquires-clario/", "date": "2026-03-25", "summary": "Thermo Fisher Scientific has completed the acquisition of Clario, a provider of endpoint data solutions for clinical trials, for approximately $8.875 billion in cash. The deal includes additional payments based on Clario's future performance and is expected to contribute positively to Thermo Fisher's operating margin, with significant synergies projected over five years. Clario's platform has supported a large percentage of new drug approvals by the EMA and FDA, integrating trial endpoint data f", "sentiment_score": 0.480348, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher (NYSE: DHR) 2026 proxy outlines governance, pay and $9.9B Masimo deal", "url": "https://www.stocktitan.net/sec-filings/DHR/def-14a-danaher-corp-de-definitive-proxy-statement-626e62bcbf87.html", "date": "2026-03-25", "summary": "Danaher's 2026 proxy statement details upcoming annual meeting proposals, including the election of directors, ratification of Ernst & Young LLP as auditor, an advisory vote on executive compensation, and approval of amendments to the Omnibus Incentive Plan. The company highlights strong 2025 financial performance with $24.6 billion in sales and outlines its agreement to acquire Masimo Corporation for $9.9 billion. The proxy also emphasizes Danaher's commitment to robust corporate governance pra", "sentiment_score": 0.195255, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.700856, "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions", "url": "https://www.businesswire.com/news/home/20260325458608/en/Thermo-Fisher-Scientific-and-SHL-Medical-Collaborate-to-Deliver-Fully-Integrated-Drug-Device-Solutions", "date": "2026-03-25", "summary": "Thermo Fisher Scientific and SHL Medical have entered a strategic collaboration and expanded capacity at Thermo Fisher's Ridgefield, NJ site to offer fully integrated drug-device solutions in the U.S. This partnership will combine sterile fill-finish manufacturing with SHL Medical's Molly® autoinjector platform, device final assembly, and packaging. The initiative aims to simplify supply chains, accelerate timelines, and address the growing demand for patient-centric, self-administered injectabl", "sentiment_score": 0.032634, "sentiment_label": "Neutral", "relevance_score": 0.309865, "sentiment": { "label": "positive", "score": 0.241, "confidence": 0.24 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific completes Clario Holdings acquisition", "url": "https://medicalbuyer.co.in/thermo-fisher-scientific-completes-clario-holdings-acquisition/", "date": "2026-03-25", "summary": "Thermo Fisher Scientific has completed its acquisition of Clario Holdings Inc. for $8.875 billion in cash, with potential earnout payments. Clario's expertise in integrating clinical trial endpoint data will enhance Thermo Fisher's clinical research offerings, allowing for faster and more informed drug development. The acquisition is expected to contribute $0.45 to Thermo Fisher's adjusted EPS in the first year and achieve significant synergy realized over five years.", "sentiment_score": 0.496445, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. $TMO Stake Decreased by Professional Advisory Services Inc.", "url": "https://www.marketbeat.com/instant-alerts/filing-thermo-fisher-scientific-inc-tmo-stake-decreased-by-professional-advisory-services-inc-2026-03-25/", "date": "2026-03-25", "summary": "Professional Advisory Services Inc. reduced its stake in Thermo Fisher Scientific Inc. by 14.3% in Q4 2025, selling 8,491 shares and now holding 51,020 shares valued at $29.56 million. Despite this, Thermo Fisher beat Q4 earnings and revenue estimates, and analysts have a \"Moderate Buy\" rating with an average target price of $633.68. The company also increased its quarterly dividend to $0.47, though recent insider activity shows sales by executives.", "sentiment_score": 0.16693, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "U.S. Compound Management Market Is Going to Boom | Thermo Fisher", "url": "https://www.openpr.com/news/4439576/u-s-compound-management-market-is-going-to-boom-thermo-fisher", "date": "2026-03-25", "summary": "Coherent Market Insights has published a report on the \"U.S. Compound Management Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033\". The report provides an in-depth analysis of market performance, competition, regional distribution, and growth potential, making it a valuable tool for entrepreneurs, investors, and business strategists. It also includes key market players, segmentation by end-user, research methodology, and strategic points of analysis.", "sentiment_score": 0.703609, "sentiment_label": "Bullish", "relevance_score": 0.948982, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "The Irish Times", "title": "Second-half charge sends Ulster past 14-man Zebre", "description": "Simone Gesi red card rallies hosts in Parma", "url": "https://www.irishtimes.com/sport/rugby/2026/03/28/second-half-charge-sends-ulster-past-14-man-zebre/", "date": "2026-03-28", "published_at": "2026-03-28T22:16:15Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "Ulster get back to winning ways against Zebre", "description": "A disjointed Ulster side pick up a hard-fought and much-needed 28-qw win over bottom side Zebre in the United Rugby Championship in Parma.", "url": "https://www.bbc.com/sport/articles/cn89rvzk923o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-03-28", "published_at": "2026-03-28T21:43:30Z", "sentiment": { "label": "positive", "score": 0.891, "confidence": 0.89 } }, { "source": "news", "source_name": "BBC News", "title": "Ulster get back to winning ways against Zebre", "description": "A disjointed Ulster side pick up a hard-fought and much-needed 28-qw win over bottom side Zebre in the United Rugby Championship in Parma.", "url": "https://www.bbc.com/sport/articles/cn89rvzk923o", "date": "2026-03-28", "published_at": "2026-03-28T21:43:25Z", "sentiment": { "label": "positive", "score": 0.891, "confidence": 0.89 } }, { "source": "news", "source_name": "RTE", "title": "Devine intervention as Connacht maintain winning run", "description": "Matthew Devine's try seven minutes from time saw Connacht edge past Ospreys in a 21-14 arm-wrestle at Dexcom Stadium, as Stuart Lancaster's side maintained their impressive recent form.", "url": "https://www.rte.ie/sport/united-rugby-championship/2026/0328/1565651-devine-intervention-as-connacht-maintain-winning-run/", "date": "2026-03-28", "published_at": "2026-03-28T16:56:04Z", "sentiment": { "label": "positive", "score": 0.772, "confidence": 0.77 } }, { "source": "news", "source_name": "BBC News", "title": "Lions overpower four-try Dragons in Johannesburg", "description": "Lions overpower Dragons at Ellis Park in the United Rugby Championship but Welsh side earn deserved four-try bonus.", "url": "https://www.bbc.com/sport/rugby-union/articles/cr71e1g7vm1o", "date": "2026-03-28", "published_at": "2026-03-28T16:25:34Z", "sentiment": { "label": "positive", "score": 0.823, "confidence": 0.82 } }, { "source": "news", "source_name": "The42", "title": "Big guns return as Leinster secure bonus-point win in United Rugby Championship over Scarlets", "description": "Leo Cullen’s side move up to third in URC table.", "url": "https://www.the42.ie/leinster-scarlets-urc-report-6997200-Mar2026/", "date": "2026-03-27", "published_at": "2026-03-27T22:26:54Z", "sentiment": { "label": "positive", "score": 0.898, "confidence": 0.9 } }, { "source": "news", "source_name": "BBC News", "title": "Glasgow stretch lead in URC after Benetton win", "description": "Glasgow Warriors stretched their lead at the top of the United Rugby Championship with a bonus-point win over Benetton at Scotstoun.", "url": "https://www.bbc.com/sport/rugby-union/articles/cjd8emlxjzjo", "date": "2026-03-27", "published_at": "2026-03-27T22:01:49Z", "sentiment": { "label": "positive", "score": 0.934, "confidence": 0.93 } }, { "source": "news", "source_name": "BBC News", "title": "Faletau injured in Cardiff's defeat by Sharks", "description": "Wales great Taulupe Faletau suffers injury as Cardiff suffer 21-15 defeat by Sharks in the United Rugby Championship.", "url": "https://www.bbc.com/sport/rugby-union/articles/cg405q65g1zo", "date": "2026-03-27", "published_at": "2026-03-27T19:04:12Z", "sentiment": { "label": "negative", "score": -0.807, "confidence": 0.81 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Small Animal Imaging (in-Vivo) Market Report 2026-2030: Advanced Imaging Modalities Drive Expansion in Preclinical Research Activities", "description": "The market is poised for growth, driven by rising precision medicine tools demand, AI diagnostics, and healthcare spending The market is poised for growth, driven by rising precision medicine tools demand, AI diagnostics, and healthcare spending", "url": "https://www.globenewswire.com/news-release/2026/03/27/3263832/28124/en/Small-Animal-Imaging-in-Vivo-Market-Report-2026-2030-Advanced-Imaging-Modalities-Drive-Expansion-in-Preclinical-Research-Activities.html", "date": "2026-03-27", "published_at": "2026-03-27T14:16:00Z", "sentiment": { "label": "positive", "score": 0.802, "confidence": 0.8 } }, { "source": "news", "source_name": "PR Newswire UK", "title": "Human Identification Market worth $1.69 billion by 2031 | MarketsandMarkets™", "description": "DELRAY BEACH, Fla., March 27, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Human Identification Market is projected to grow from about USD 1.01 billion in 2026 to USD 1.69 billion by 2031, at a CAGR of 10.9%. Browse 285 market data tables and 60 …", "url": "https://www.prnewswire.co.uk/news-releases/human-identification-market-worth-1-69-billion-by-2031--marketsandmarkets-302727035.html", "date": "2026-03-27", "published_at": "2026-03-27T14:01:00Z", "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "Plos.org", "title": "Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study", "description": "Author summary The cytochrome P-450 (CYP) isoenzyme 2D6 metabolizes up to 25% of commonly used medicines, including primaquine (PQ), which is the only widely available drug that eliminates latent hypnozoites, thus preventing relapses of Plasmodium vivax malar…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014160", "date": "2026-03-27", "published_at": "2026-03-27T14:00:00Z", "sentiment": { "label": "negative", "score": -0.296, "confidence": 0.3 } }, { "source": "news", "source_name": "Plos.org", "title": "5-HT1B receptor agonists promote Schwann cell myelination", "description": "Congenital demyelinating peripheral neuropathy causes severe sensorimotor defects, affecting patient mobility. To identify therapeutic compounds for peripheral hypomyelinating neuropathy, we performed an unbiased screening of annotated compound library by in …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345946", "date": "2026-03-27", "published_at": "2026-03-27T14:00:00Z", "sentiment": { "label": "negative", "score": -0.421, "confidence": 0.42 } }, { "source": "news", "source_name": "Plos.org", "title": "Liquid-liquid phase separation mediated immune evasion of respiratory syncytial virus against oligoadenylate synthetase-RNase L pathway", "description": "Author summary Biomolecular condensates are increasingly recognized as key mechanisms of subcellular organization. The role of viral infection-mediated phase-separated structures, called inclusion bodies (IBs), in replication has already been characterized in…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014089", "date": "2026-03-27", "published_at": "2026-03-27T14:00:00Z", "sentiment": { "label": "positive", "score": 0.713, "confidence": 0.71 } }, { "source": "news", "source_name": "Plos.org", "title": "Discovery and cryoEM structure of FPM13, a periplasmic metalloprotein unique to Francisella", "description": "Author summary Francisella tularensis, the cause of tularemia, is a highly infectious bacterium and a Tier 1 U.S. Federal Select Agent with sophisticated survival strategies. While studying Francisella novicida, a model organism closely related genetically to…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014024", "date": "2026-03-27", "published_at": "2026-03-27T14:00:00Z", "sentiment": { "label": "positive", "score": 0.557, "confidence": 0.56 } }, { "source": "news", "source_name": "BBC News", "title": "Edwards back as Morgan leads Ospreys at Connacht", "description": "Wales fly-half Dan Edwards returns from Six Nations duty and Jac Morgan is back in Ospreys' starting side for their United Rugby Championship trip to Connacht on Saturday.", "url": "https://www.bbc.com/sport/rugby-union/articles/ce8ljpy5l91o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-03-27", "published_at": "2026-03-27T12:17:14Z", "sentiment": { "label": "positive", "score": 0.691, "confidence": 0.69 } }, { "source": "news", "source_name": "Barchart.com", "title": "What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release", "description": "Thermo Fisher Scientific will release its first-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.", "url": "https://www.barchart.com/story/news/1000546/what-you-need-to-know-ahead-of-thermo-fisher-scientific-s-earnings-release", "date": "2026-03-27", "published_at": "2026-03-27T09:48:16Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Is Thermo Fisher Scientific (TMO) One of the Best Conservative Stocks to Buy Right Now?", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_33ff1240-b142-43c0-bc76-475ff17b132d", "date": "2026-03-26", "published_at": "2026-03-26T15:50:35Z", "sentiment": { "label": "positive", "score": 0.637, "confidence": 0.64 } }, { "source": "news", "source_name": "Plos.org", "title": "Maternal undernutrition reprograms reproductive and metabolic phenotypes in female offspring of the rabbit model", "description": "Maternal undernutrition during pregnancy in mammals can induce long-term effects in offspring health through molecular programming of the gametes. Using the rabbit model, this study investigates whether maternal food restriction (FR) during the first two-thir…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345066", "date": "2026-03-26", "published_at": "2026-03-26T14:00:00Z", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Plos.org", "title": "Serotonin signaling modulates growth and motility in juvenile Fasciola hepatica", "description": "Author summary The liver fluke, Fasciola hepatica, causes fasciolosis, a neglected tropical disease that poses a significant burden on human and animal health. There is no vaccine for fasciolosis and treatment relies on a single drug, triclabendazole, to cont…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014097", "date": "2026-03-26", "published_at": "2026-03-26T14:00:00Z", "sentiment": { "label": "negative", "score": -0.625, "confidence": 0.62 } }, { "source": "news", "source_name": "Plos.org", "title": "Oligomeric lactic acid nanoplastics induce intrauterine growth restriction in mice by disrupting GATA2-mediated placental vascular development", "description": "Polylactic acid is a widely used biodegradable plastic, which can be broken down into oligomeric lactic acid (OLA) nanoplastics. This study shows that OLA particles can accumulate in the placenta and fetus of pregnant mice and induce placental vascular dyspla…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003676", "date": "2026-03-26", "published_at": "2026-03-26T14:00:00Z", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Plos.org", "title": "Genetic variations associated with immediate hypersensitivity reactions to iodinated contrast media: A whole exome sequencing study", "description": "Objective The use of iodinated contrast media (ICM) in computed tomography (CT) has increased significantly; however, hypersensitivity reactions (HSRs) remain a concern. This study aimed to investigate genetic factors associated with ICM-induced immediate HSR…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345313", "date": "2026-03-26", "published_at": "2026-03-26T14:00:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Plos.org", "title": "Urinary tract infections, risk factors and antimicrobial resistance patterns in heart failure patients on sodium-glucose transporter 2 inhibitors: Evidence from Jakaya Kikwete Cardiac Institute in Tanzania", "description": "Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors such as dapagliflozin and empagliflozin are increasingly used in heart failure (HF) management due to their cardiovascular benefits. However, glycosuria induced by SGLT2 inhibition may increase the…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0344986", "date": "2026-03-26", "published_at": "2026-03-26T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "BBC News", "title": "Forget URC - Scarlets face a Test match in Dublin", "description": "Scarlets make five changes to their side as they prepare to face Leinster at Dublin's Aviva Stadium in the United Rugby Championship.", "url": "https://www.bbc.com/sport/rugby-union/articles/c3dl5vz4v3po", "date": "2026-03-26", "published_at": "2026-03-26T12:11:13Z", "sentiment": { "label": "positive", "score": 0.586, "confidence": 0.59 } }, { "source": "news", "source_name": "BBC News", "title": "Botham returns as Cardiff shuffle pack for Sharks", "description": "Wales flanker James Botham returns to the Cardiff side for Friday's United Rugby Championship game against Sharks in Durban.", "url": "https://www.bbc.com/sport/rugby-union/articles/cg405q65g1zo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-03-26", "published_at": "2026-03-26T12:04:07Z", "sentiment": { "label": "positive", "score": 0.691, "confidence": 0.69 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Nanocapsules Market Size is Expected to Reach USD 5.92 Billion by 2035 Owing to the Potential Benefits Offered by Nanotechnology Globally | SNS Insider", "description": "Nanocapsules market to reach USD 5.92 Bn by 2035, driven by targeted drug delivery, rising oncology demand, and strong R&D and regulatory support globally.", "url": "https://www.globenewswire.com/news-release/2026/03/26/3262806/0/en/Nanocapsules-Market-Size-is-Expected-to-Reach-USD-5-92-Billion-by-2035-Owing-to-the-Potential-Benefits-Offered-by-Nanotechnology-Globally-SNS-Insider.html", "date": "2026-03-26", "published_at": "2026-03-26T10:01:00Z", "sentiment": { "label": "positive", "score": 0.807, "confidence": 0.81 } }, { "source": "news", "source_name": "Mit.edu", "title": "Why solid-state batteries keep short-circuiting", "description": "MIT researchers discovered that dendrites, cracks that harm the performance of solid-state batteries, can grow at far lower stresses than previously understood. The findings reveal why developing stronger solid electrolytes alone hasn’t solved the dendrite pr…", "url": "https://news.mit.edu/2026/why-solid-state-batteries-keep-short-circuiting-0325", "date": "2026-03-25", "published_at": "2026-03-25T16:00:00Z", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "Plos.org", "title": "Microalgal colony blot: A simple and rapid method for direct detection of recombinant protein production in microalgae colonies", "description": "Microalgae have emerged as a versatile biotechnological platform, promising to become an efficient source of commodities such as food, feed, and biofuels, but these organisms have also sparked profound scientific and commercial interest for their potential in…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345458", "date": "2026-03-25", "published_at": "2026-03-25T14:00:00Z", "sentiment": { "label": "positive", "score": 0.775, "confidence": 0.78 } }, { "source": "news", "source_name": "Plos.org", "title": "Fis suppresses late-stage virulence gene expression in Yersinia pseudotuberculosis at environmental temperatures", "description": "Author summary Bacterial pathogens must precisely control virulence gene expression to transition successfully between environmental reservoirs and host infection. In Yersinia pseudotuberculosis, the nucleoid-associated protein Fis plays a crucial role in coo…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014105", "date": "2026-03-25", "published_at": "2026-03-25T14:00:00Z", "sentiment": { "label": "positive", "score": 0.637, "confidence": 0.64 } }, { "source": "news", "source_name": "Plos.org", "title": "STR analysis of human DNA recovered from bathwater and other water samples for forensic identification", "description": "Human DNA is widely distributed in the environment and can be released into water through skin cells, sweat, and other biological materials. In forensic investigations involving drowning or suspected immersion events, bathwater represents an underexplored but…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345878", "date": "2026-03-25", "published_at": "2026-03-25T14:00:00Z", "sentiment": { "label": "negative", "score": -0.426, "confidence": 0.43 } }, { "source": "news", "source_name": "Plos.org", "title": "Comparative studies of the effects of Naja ashei venom-derived proteins on model and native lipid membranes", "description": "Author summary Animal venoms contain many proteins that may serve as promising leads for developing new anticancer therapies. In this study, we examined how specific proteins isolated from Naja ashei venom interact with cancer cell membranes. We focused on tw…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014122", "date": "2026-03-25", "published_at": "2026-03-25T14:00:00Z", "sentiment": { "label": "negative", "score": -0.34, "confidence": 0.34 } }, { "source": "news", "source_name": "Nature.com", "title": "Genomic history of early dogs in Europe", "description": "Genome-wide analysis shows European dogs existed by 14,200 years ago, were already genetically distinct, received less Neolithic Southwest Asian admixture than humans did and contributed substantially to later European dogs.", "url": "https://www.nature.com/articles/s41586-026-10112-7", "date": "2026-03-25", "published_at": "2026-03-25T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Parasites trigger epithelial cell crosstalk to drive gut–brain signalling", "description": "Paracrine signalling between tuft cells and enterochromaffin cells is a key mode of immune–sensory and gut–brain communication, and accounts for the pattern of gastrointestinal symptoms that occurs during parasite infections.", "url": "https://www.nature.com/articles/s41586-026-10281-5", "date": "2026-03-25", "published_at": "2026-03-25T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity", "description": "NMDAR expression is sufficient to induce B cell recruitment and affinity maturation, resulting in receptor-modulating antibodies that connect anti-cancer immunity and autoimmunity.", "url": "https://www.nature.com/articles/s41586-026-10278-0", "date": "2026-03-25", "published_at": "2026-03-25T00:00:00Z", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "Nature.com", "title": "Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma", "description": "Androgen activity in the male embryonic hindbrain prolongs hindbrain differentiation in male individuals and drives sex differences in the incidence and prognosis of posterior fossa type A (PFA) ependymoma, an aggressive childhood brain tumour.", "url": "https://www.nature.com/articles/s41586-026-10264-6", "date": "2026-03-25", "published_at": "2026-03-25T00:00:00Z", "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Virus Filtration Market Size Projected to Reach USD 15 Billion by 2035, Driven by Surging Biologics Demand and 14.3% CAGR – SNS Insider", "description": "Growing biologics pipeline, rising cell & gene therapy investments, and strict viral safety mandates from global regulators are driving the virus filtration market through 2035. Growing biologics pipeline, rising cell & gene therapy investments, and strict vi…", "url": "https://www.globenewswire.com/news-release/2026/03/24/3261531/0/en/Virus-Filtration-Market-Size-Projected-to-Reach-USD-15-Billion-by-2035-Driven-by-Surging-Biologics-Demand-and-14-3-CAGR-SNS-Insider.html", "date": "2026-03-24", "published_at": "2026-03-24T15:30:00Z", "sentiment": { "label": "positive", "score": 0.586, "confidence": 0.59 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_341ff2d7-de3d-40fd-a342-2ccbef3e012c", "date": "2026-03-24", "published_at": "2026-03-24T14:43:06Z", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™", "description": "Growing complexity of global clinical trials and adoption of digital supply chain solutions accelerate market expansion at 8.9% CAGR Growing complexity of global clinical trials and adoption of digital supply chain solutions accelerate market expansion at 8.9…", "url": "https://www.globenewswire.com/news-release/2026/03/24/3261460/0/en/Clinical-Trial-Supplies-Market-to-Reach-USD-8-18-Billion-by-2030-MarketsandMarkets.html", "date": "2026-03-24", "published_at": "2026-03-24T14:30:00Z", "sentiment": { "label": "positive", "score": 0.599, "confidence": 0.6 } }, { "source": "news", "source_name": "Plos.org", "title": "Hepatitis E virus exposure and risk factors among ethnic minority populations in Northern Vietnam", "description": "Background Hepatitis E virus (HEV) causes sporadic outbreaks worldwide, with zoonotic and waterborne genotypes contributing to infections. In Vietnam, HEV genotypes 3 and 4 circulate among humans and swine, but data from remote, ethnic minority populations re…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345566", "date": "2026-03-24", "published_at": "2026-03-24T14:00:00Z", "sentiment": { "label": "negative", "score": -0.141, "confidence": 0.14 } }, { "source": "news", "source_name": "Plos.org", "title": "Integrating natural gradients and controlled assays to reveal bacterial responses to cadmium in Theobroma cacao L., soils", "description": "Cadmium (Cd), a toxic heavy metal found in agricultural landscapes worldwide, has been pointed out in cropped soils with Theobroma cacao L., as one of the main contaminants that translocate into plant tissues. Among the factors linked to cadmium translocation…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345645", "date": "2026-03-24", "published_at": "2026-03-24T14:00:00Z", "sentiment": { "label": "positive", "score": 0.361, "confidence": 0.36 } }, { "source": "news", "source_name": "Plos.org", "title": "mTOR signaling regulates demand-adapted hematopoiesis and metabolic reprogramming required for an effective cellular immune response in Drosophila melanogaster larvae", "description": "Author summary The immune system relies on specialized blood cells that can rapidly develop in response to infection or injury. However, the signals that guide blood cells to adopt specific immune functions are not fully understood. In this study, we used the…", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012094", "date": "2026-03-24", "published_at": "2026-03-24T14:00:00Z", "sentiment": { "label": "positive", "score": 0.765, "confidence": 0.77 } }, { "source": "news", "source_name": "Plos.org", "title": "The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification", "description": "Gastric cancer (GC) is one of the most common and lethal cancers globally. methyltransferase-like 3 (METTL3)-mediated N6-methyladenosine (m6A) RNA methylation plays a crucial role in tumor initiation and progression by regulating RNA function. STM2457, a high…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345744", "date": "2026-03-24", "published_at": "2026-03-24T14:00:00Z", "sentiment": { "label": "negative", "score": -0.893, "confidence": 0.89 } }, { "source": "news", "source_name": "Plos.org", "title": "A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms", "description": "TDP-43 pathology is a hallmark of several neurodegenerative disorders, but the connection between TDP-43 aggregation and dysfunction remains poorly understood. This study develops a quantitative cell-based reporter and a cellular model based on TDP-43 aggrega…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003662", "date": "2026-03-24", "published_at": "2026-03-24T14:00:00Z", "sentiment": { "label": "negative", "score": -0.881, "confidence": 0.88 } }, { "source": "news", "source_name": "Plos.org", "title": "Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy", "description": "Liver cancer, especially hepatocellular carcinoma (HCC), remains a major global health challenge, causing high mortality worldwide. Conventional chemotherapy often results in severe side effects due to its systemic distribution, which limits its effectiveness…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345161", "date": "2026-03-24", "published_at": "2026-03-24T14:00:00Z", "sentiment": { "label": "negative", "score": -0.829, "confidence": 0.83 } }, { "source": "news", "source_name": "Plos.org", "title": "Implications for methenamine hippurate use in recurrent urinary tract infection management: Formaldehyde resistance and altered urinary composition", "description": "Author summary The mainstay of treatment for urinary tract infections is short course antibiotics, often sufficient to clear the infection. However, a significant proportion of UTIs are recurrent, leading to frequent antibiotic consumption. The drive for bett…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014081", "date": "2026-03-24", "published_at": "2026-03-24T14:00:00Z", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "Nature.com", "title": "Nonsense-mediated mRNA decay safeguards telomeres in pluripotent stem cells", "description": "Markiewicz-Potoczny et al. report that the nonsense-mediated mRNA decay pathway protects telomeres in the absence of core Shelterin component TRF2 by regulating the stability and abundance of TRF1 at telomeres.", "url": "https://www.nature.com/articles/s41556-026-01912-0", "date": "2026-03-24", "published_at": "2026-03-24T00:00:00Z", "sentiment": { "label": "negative", "score": -0.178, "confidence": 0.18 } }, { "source": "news", "source_name": "New Zealand Herald", "title": "All Blacks Watch: Dave Rennie’s bench options on show in Super Rugby - Opinion", "description": "OPINION: Is my backside a pineapple? Some Super players would say it's up for debate.", "url": "https://www.nzherald.co.nz/sport/rugby/all-blacks/all-blacks-watch-dave-rennies-bench-options-on-show-in-super-rugby-opinion/premium/ICMZOM4QTJAX3DNO372O3GUTZ4/", "date": "2026-03-23", "published_at": "2026-03-23T22:07:08Z", "sentiment": { "label": "positive", "score": 0.832, "confidence": 0.83 } }, { "source": "news", "source_name": "The Irish Times", "title": "Owen Doyle: Oscar Jegou incident shows why World Rugby needs to look at disciplinary protocols", "description": "French flanker’s four-match ban for eye gouging shows up many of the shortcomings of the system", "url": "https://www.irishtimes.com/sport/rugby/2026/03/23/owen-doyle-oscar-jegou-incident-shows-why-world-rugby-needs-to-look-at-disciplinary-protocols/", "date": "2026-03-23", "published_at": "2026-03-23T18:40:30Z", "sentiment": { "label": "negative", "score": -0.557, "confidence": 0.56 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Oncology Clinical Trials Market Forecast 2026-2035 - AI Revolutionizes Oncology Clinical Trials: Boosts Recruitment, Optimizes Protocols", "description": "Dublin, March 23, 2026 (GLOBE NEWSWIRE) -- The \"Oncology Clinical Trials Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering.The global oncology clinical trials market continues to e…", "url": "https://www.globenewswire.com/news-release/2026/03/23/3260655/28124/en/Oncology-Clinical-Trials-Market-Forecast-2026-2035-AI-Revolutionizes-Oncology-Clinical-Trials-Boosts-Recruitment-Optimizes-Protocols.html", "date": "2026-03-23", "published_at": "2026-03-23T16:05:00Z", "sentiment": { "label": "positive", "score": 0.84, "confidence": 0.84 } }, { "source": "news", "source_name": "Plos.org", "title": "Canonical WNT signalling governs Echinococcus metacestode development", "description": "Author summary Alveolar echinococcosis (AE) is a lethal disease caused by the cancer-like growth of the metacestode larva of the tapeworm Echinococcus multilocularis. From a developmental perspective, the Echinococcus metacestode is an unusual biological stru…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014046", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Plos.org", "title": "Transcriptional and functional characterization of terpene synthase genes of the aromatic plant Plectranthus hadiensis", "description": "Plectranthus hadiensis (Lamiaceae) is recognized for its rich terpene content and potential applications in agriculture, medicine, and aromatherapy. Terpenes are major constituents of P. hadiensis essential oil, yet its terpene synthase (TPS) genes remain ins…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345772", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "positive", "score": 0.557, "confidence": 0.56 } }, { "source": "news", "source_name": "Plos.org", "title": "Assessment of references for the quantitative analysis of LINE-1 and Alu methylation in cellular DNA and circulating cell-free DNA of cancer patients", "description": "The LINE-1 and Alu retrotransposon elements, with more than 90% of their sequences being methylated, contribute to 30% of the human genome. Their hypomethylation profile, representing global methylation in cellular and cell-free DNA (cfDNA) from cancer, has b…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345087", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "negative", "score": -0.869, "confidence": 0.87 } }, { "source": "news", "source_name": "Plos.org", "title": "Recombinant Potyvirus lilimaculae in asymptomatic Galanthus nivalis: Ecological and evolutionary implications", "description": "Snowdrops are economically important early-spring flowering geophytes. They are protected both in Hungary and across the European Union, and their international trade is regulated under the Washington Convention. Despite their importance, virological research…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345337", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "positive", "score": 0.38, "confidence": 0.38 } }, { "source": "news", "source_name": "Plos.org", "title": "Microsporidian Encephalitozoon hellem inhibits host mitophagy by inducing ERAD to degrade BNIP3L", "description": "Author summary Microsporidian parasites, known for their intricate manipulation of host cellular processes, have been found to employ novel mechanisms in disrupting mitochondrial homeostasis. This study investigates Encephalitozoon hellem, a human-pathogenic …", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014078", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "negative", "score": -0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "Plos.org", "title": "The differential roles of Giardia duodenalis-secreted tenascins in inducing intestinal epithelial cell apoptosis and the attributed EGFR-STAT3 axis regulation", "description": "Author summary IEC apoptosis is a crucial part of giardiasis development and the causative mechanisms behind the process remain poorly understood to date. During Giardia infection, trophozoites adhere tightly to the small intestine, and the physical attachmen…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014153", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design", "description": "Author summary Coronaviruses pose a constant threat to global health due to the potential transmission from animal to human hosts. Vaccine development has been limited by the instability of the coronavirus spike protein in the prefusion state and since future…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013998", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "negative", "score": -0.649, "confidence": 0.65 } }, { "source": "news", "source_name": "Plos.org", "title": "Application of CRISPR/Cas13a system on the rapid detection of Salmonella spp", "description": "Author summary Prompt and precise detection of Salmonella spp. is crucial not only for early diagnosis and effective treatment, but also for preventing transmission, controlling outbreaks, and screening asymptomatic Salmonella carrier. In this study, we estab…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014150", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "Plos.org", "title": "Exploring anatomical and geographical drivers of the microbiota in wild capybaras (Hydrochoerus hydrochaeris): Baseline Data for zoonotic risk assessment", "description": "Capybaras (Hydrochoerus hydrochaeris) play important ecological, cultural, and economic roles in Colombia, particularly in the Orinoco region. Their adaptability to human-modified environments increases contact with humans and animals, raising concerns about …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345409", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Plos.org", "title": "Effects of GABAAR modulators CL218872 and MRK-016 on neural repair and synaptic plasticity in mice with Intracerebral hemorrhage", "description": "Background Intracerebral hemorrhage (ICH) is a devastating condition characterized by rapid onset, high rates of disability and mortality, and prolonged recovery. Dysregulated γ-aminobutyric acid type A receptor (GABAAR) signaling contributes to ICH-induced n…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345025", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "negative", "score": -0.649, "confidence": 0.65 } }, { "source": "news", "source_name": "Plos.org", "title": "Hypoxia- and inflammation-driven preconditioning modulates angiogenic and metabolic pathways in canine adipose-derived mesenchymal stem cells", "description": "The immunomodulatory properties of exogenous mesenchymal stem cells (MSCs) have been the target of research in immune-mediated diseases and organ transplants. However, the altered microenvironment decrease MSCs capabilities and survival post-transplantation. …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345360", "date": "2026-03-23", "published_at": "2026-03-23T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Banzai Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities", "description": "Banzai Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities...", "url": "https://www.globenewswire.com/news-release/2026/03/23/3260512/0/en/Banzai-Reaches-Deal-to-Acquire-Assets-of-ConnectAndSell-a-Profitable-Company-More-Than-Doubling-Annual-Revenue-and-Expanding-AI-Platform-Capabilities.html", "date": "2026-03-23", "published_at": "2026-03-23T13:30:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "Thenation.com", "title": "A Dangerous and Consistent Misreading of Trump’s Appeal", "description": "Corbin Trent\n\n\n\nTrump didn’t win by moderating. He won by attacking a system millions already believed was broken.\r\n\n\r\n\n\nThe post A Dangerous and Consistent Misreading of Trump’s Appeal appeared first on The Nation.", "url": "https://www.thenation.com/?post_type=article&p=591050", "date": "2026-03-23", "published_at": "2026-03-23T09:00:00Z", "sentiment": { "label": "negative", "score": -0.586, "confidence": 0.59 } }, { "source": "news", "source_name": "Nature.com", "title": "Mechanisms of active wetting and fluidification in epithelial cell collectives", "description": "Active wetting and fluidification of breast cancer epithelia are shown to be controlled by IRSp53 and Afadin, cell adhesion proteins that regulate multicellular viscosity and tensile state during tumour progression.", "url": "https://www.nature.com/articles/s41563-026-02553-2", "date": "2026-03-23", "published_at": "2026-03-23T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "Title-chasing Stormers overcome tenacious Dragons", "description": "Stormers move back to second in the United Rugby Championship with a four-try victory against Dragons in Cape Town.", "url": "https://www.bbc.com/sport/rugby-union/articles/c79jwnyz719o", "date": "2026-03-22", "published_at": "2026-03-22T15:08:03Z", "sentiment": { "label": "positive", "score": 0.691, "confidence": 0.69 } }, { "source": "news", "source_name": "BBC News", "title": "Sharks put Munster to the sword in URC encounter", "description": "Sharks score seven tries as they inflict a humbling 45-0 defeat on Munster in Saturday's United Rugby Championship game in Durban.", "url": "https://www.bbc.com/sport/rugby-union/articles/c239k43gpj2o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-03-21", "published_at": "2026-03-21T17:19:17Z", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "BBC News", "title": "Sharks put Munster to the sword in URC encounter", "description": "Sharks score seven tries as they inflict a humbling 45-0 defeat on Munster in Saturday's United Rugby Championship game in Durban.", "url": "https://www.bbc.com/sport/rugby-union/articles/c239k43gpj2o", "date": "2026-03-21", "published_at": "2026-03-21T17:19:12Z", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "BBC News", "title": "Clovers book spot in Celtic Challenge final", "description": "Clovers secure their spot in the Celtic Challenge final with a 35-20 win over Gwalia Lightning at Dexcom Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/cre1jw8wynqo", "date": "2026-03-21", "published_at": "2026-03-21T14:02:40Z", "sentiment": { "label": "positive", "score": 0.778, "confidence": 0.78 } }, { "source": "news", "source_name": "BBC News", "title": "Connacht secure bonus-point win over Ulster", "description": "Connacht produce a powerful second-half display to secure a statement United Rugby Championship victory over Ulster at the Affidea Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/c75knp472w6o", "date": "2026-03-20", "published_at": "2026-03-20T22:56:31Z", "sentiment": { "label": "positive", "score": 0.944, "confidence": 0.94 } }, { "source": "news", "source_name": "BBC News", "title": "Scarlets sweep aside Zebre with bonus-point win", "description": "Scarlets came out on top of the United Rugby Championship basement battle, running in six tries against a lacklustre Zebre.", "url": "https://www.bbc.com/sport/rugby-union/articles/c3wlw3e9jx1o", "date": "2026-03-20", "published_at": "2026-03-20T21:59:44Z", "sentiment": { "label": "positive", "score": 0.827, "confidence": 0.83 } }, { "source": "news", "source_name": "Plos.org", "title": "Shotgun metagenomic analysis of the oral microbiomes of children with noma", "description": "Author summary Noma is a rapidly progressing necrotic disease that destroys the tissues of the mouth and face, mainly affecting children living in abject poverty. Although antibiotic treatment can be lifesaving, the microbes involved in noma are still largely…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014118", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.784, "confidence": 0.78 } }, { "source": "news", "source_name": "Plos.org", "title": "CLDN3 inhibits rotavirus attachment by targeting residue 74 of VP7", "description": "Author summary Rotavirus (RV) is a major global pathogen, and understanding the intricate battle between the virus and host defenses is critical. While it is known that RV infection disrupts tight junction proteins like claudins (CLDNs) to facilitate its entr…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014045", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "positive", "score": 0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "Plos.org", "title": "Signal peptidase complex mediates rotavirus VP7 processing and virion assembly", "description": "Author summary Previous reports demonstrated that SPC is involved in the replication cycles of several members of the flavivirus family and human T-cell leukemia virus type 1 (HTLV-1). As an ER-resident outer capsid protein, rotavirus VP7 must undergo proper …", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013688", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Targeting Leishmania donovani Sphingosine Kinase 1 using PF-543 enhances immune response and limits parasite load", "description": "Author summary Leishmaniasis, a neglected tropical disease, has limited available treatments and is becoming more resistant to medications. In this study, we explored the therapeutic potential of PF-543, a potent Sphingosine Kinase 1 (SphK1) inhibitor (demons…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013102", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "Plos.org", "title": "Isolation methods influence the biological properties of Wharton’s Jelly-derived mesenchymal stem cells: A comparative study of yield, viability, proliferation, differentiation potential, and proteomic profiles", "description": "Background Mesenchymal stem cells derived from Wharton’s Jelly (WJ-MSCs) are an attractive cell source for regenerative medicine due to high proliferative capacity, non-invasive accessibility, and minimal ethical constraints. However, their therapeutic effica…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345081", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "positive", "score": 0.542, "confidence": 0.54 } }, { "source": "news", "source_name": "Plos.org", "title": "EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model", "description": "Author summary Individual variation in response to Epstein-Barr virus (EBV) infection can lead to diverse pathogenic outcomes, ranging from cancers to autoimmune disease. To study this variation, we analyzed immune cell response and viral dynamics during the …", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013746", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "positive", "score": 0.84, "confidence": 0.84 } }, { "source": "news", "source_name": "Plos.org", "title": "Retroviral intasome architecture shapes the dynamics of target DNA search and integration", "description": "Author summary Retroviruses insert their genetic material into the DNA of infected cells, a process carried out by a viral enzyme called integrase. Integrase molecules assemble with viral DNA ends to form a complex known as the intasome, which joins the viral…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014070", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Plos.org", "title": "Intestinal barrier damage is associated with fine particulate matter (PM2.5)-induced pathological aortic injury in mice", "description": "Chronic exposure to air pollution is associated with an increased cardiovascular disease (CVD) risk, and inflammation induced by fine particulate matter (PM2.5) exposure is a key driver in CVD development. However, the mechanism by which PM2.5 causes cardiaco…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345110", "date": "2026-03-20", "published_at": "2026-03-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.772, "confidence": 0.77 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "DNA Sequencing Market to Expand at 18%+ CAGR by 2031 as Genomics Research and Precision Medicine Drive Global Adoption, Says Mordor Intelligence", "description": "The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing precision medicine initiatives, with North America leading the m…", "url": "https://www.globenewswire.com/news-release/2026/03/20/3259684/0/en/DNA-Sequencing-Market-to-Expand-at-18-CAGR-by-2031-as-Genomics-Research-and-Precision-Medicine-Drive-Global-Adoption-Says-Mordor-Intelligence.html", "date": "2026-03-20", "published_at": "2026-03-20T11:39:00Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape", "description": "Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The \"ELISpot & FluoroSpot Assay Market Report: Trends, Forecast and Competitive Analysis to 2031\" has been added to ResearchAndMarkets.com's offering.", "url": "https://www.globenewswire.com/news-release/2026/03/20/3259667/28124/en/ELISpot-FluoroSpot-Assay-Market-Report-2026-2031-Mabtech-Oxford-Immunotec-Global-and-Cellular-Technology-Dominate-the-Landscape.html", "date": "2026-03-20", "published_at": "2026-03-20T11:00:00Z", "sentiment": { "label": "positive", "score": 0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Decentralized Clinical Trials Market Report 2026: Review of 2022-2025 with CAGR Projections Through 2030", "description": "Key opportunities include expanding cloud-based platforms, leveraging interventional and oncology trials, targeting pharmaceutical companies and CROs, and focusing on growth in regions like Asia-Pacific and Europe. Emphasis on sustainability and ESG practices…", "url": "https://www.globenewswire.com/news-release/2026/03/20/3259643/28124/en/Global-Decentralized-Clinical-Trials-Market-Report-2026-Review-of-2022-2025-with-CAGR-Projections-Through-2030.html", "date": "2026-03-20", "published_at": "2026-03-20T10:47:00Z", "sentiment": { "label": "positive", "score": 0.772, "confidence": 0.77 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 Million - Analysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More", "description": "Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The \"U.S. Exosomes Market Size, Share & Trends Analysis Report by Product & Service, Application, Workflow, End Use, and Segment Forecasts, 2026-2033\" has been added to ResearchAndMarkets.com's offering.The U.S. exos…", "url": "https://www.globenewswire.com/news-release/2026/03/20/3259642/28124/en/U-S-Exosomes-Market-to-Skyrocket-During-2026-2033-Reaching-716-8-Million-Analysis-of-Lucrative-Business-Opportunities-and-Key-Players-Danaher-Thermo-Fisher-Scientific-Hologic-Fujif.html", "date": "2026-03-20", "published_at": "2026-03-20T10:45:00Z", "sentiment": { "label": "positive", "score": 0.681, "confidence": 0.68 } }, { "source": "news", "source_name": "Nature.com", "title": "Functional integration of an autologous engineered esophagus in a large-animal model", "description": "A tissue-engineered esophageal segment is functional in minipigs.", "url": "https://www.nature.com/articles/s41587-026-03043-1", "date": "2026-03-20", "published_at": "2026-03-20T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Visualizing suborganellar lipid distribution using correlative light and electron microscopy", "description": "Lennartz et al. introduce a correlative light and electron microscopy workflow, Lipid-CLEM, combining near-native lipid probes and on-section labelling via click chemistry. Lipid-CLEM quantitatively analyses lipids in membrane nanodomains.", "url": "https://www.nature.com/articles/s41556-026-01915-x", "date": "2026-03-20", "published_at": "2026-03-20T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "PR Newswire UK", "title": "Poultry Diagnostics Market worth $0.25 billion by 2031 | MarketsandMarkets™", "description": "DELRAY BEACH, Fla., March 19, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Poultry Diagnostics Market is projected to grow from about USD 0.18 billion in 2026 to USD 0.25 billion by 2031, at a CAGR of 7.1%. Browse 480 market data Tables and 65 Fi…", "url": "https://www.prnewswire.co.uk/news-releases/poultry-diagnostics-market-worth-0-25-billion-by-2031--marketsandmarkets-302718565.html", "date": "2026-03-19", "published_at": "2026-03-19T14:30:00Z", "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Genomics Market to Reach USD 85.09 Billion by 2030 | MarketsandMarkets™", "description": "Advancements in NGS, AI-driven bioinformatics, and expanding precision medicine initiatives are positioning genomics as a strategic pillar in modern healthcare, diagnostics, and drug discovery. Advancements in NGS, AI-driven bioinformatics, and expanding prec…", "url": "https://www.globenewswire.com/news-release/2026/03/19/3259211/0/en/Genomics-Market-to-Reach-USD-85-09-Billion-by-2030-MarketsandMarkets.html", "date": "2026-03-19", "published_at": "2026-03-19T14:30:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development", "description": "The global market for decentralized clinical trials (DCTs) was valued at $8.8 billion in 2024 and is projected to reach $18.8 billion by the end of 2030....", "url": "https://www.globenewswire.com/news-release/2026/03/19/3259193/0/en/Decentralized-Clinical-Trials-Market-to-Reach-18-8-Billion-by-2030-as-Digital-Health-Infrastructure-Reshapes-Drug-Development.html", "date": "2026-03-19", "published_at": "2026-03-19T14:14:00Z", "sentiment": { "label": "positive", "score": 0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "Plos.org", "title": "Genomic evolution of SARS-CoV-2 delta variants pre- and post-omicron emergence using alignment-free machine learning models", "description": "The SARS-CoV-2 Delta variant (B.1.617.2), initially classified as a variant of concern due to its enhanced transmissibility and vaccine-escape mutations, underwent further genomic changes following the emergence of the Omicron variant (B.1.1.529). This study …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345259", "date": "2026-03-19", "published_at": "2026-03-19T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "A miniaturized, frugal RPA assay for genus-level detection of Paracoccidioides spp. in resource-limited endemic settings", "description": "Author summary Paracoccidioidomycosis (PCM) primarily affects rural populations in Latin America. Rapid, accessible tools for detecting its causative agent, Paracoccidioides spp., are urgently needed in endemic regions. We developed a simple and low-cost mole…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014101", "date": "2026-03-19", "published_at": "2026-03-19T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Lipidomic analysis of bile from patients with extrahepatic cholangiocarcinoma", "description": "Objective Cholangiocarcinoma and gallstones are significant gastrointestinal diseases with diverse etiologies and complex clinical manifestations. Understanding their underlying molecular mechanisms is crucial for advancing diagnosis and treatment strategies.…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345136", "date": "2026-03-19", "published_at": "2026-03-19T14:00:00Z", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "news", "source_name": "Plos.org", "title": "GBP2 promotes podocyte pyroptosis and contributes to the pathogenesis of pediatric lupus nephritis", "description": "Background Lupus nephritis (LN), a prevalent and serious manifestation of systemic lupus erythematosus, exhibits particularly high incidence in children, yet its pathogenesis remains incompletely elucidated. This study aimed to investigate differentially expr…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0344601", "date": "2026-03-19", "published_at": "2026-03-19T14:00:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Plos.org", "title": "Anatid herpesvirus 1 UL51 protein is palmitoylated by DHHC9 and DHHC18 for viral replication and virulence", "description": "Author summary The tegument protein UL51 is present in nearly all herpesviruses. Understanding its function and mechanism of action in viral replication and pathogenesis may provide a potential target for the development of future antiviral strategies. Using …", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014076", "date": "2026-03-19", "published_at": "2026-03-19T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Myofibrillar protein accumulation but reduced protein synthesis in PDCD4-depleted myotubes", "description": "Skeletal muscle is critical to whole-body functionality and homeostasis. The mammalian/mechanistic target of rapamycin complex 1 (mTORC1) is a nutrient/growth-factor sensitive positive regulator of skeletal muscle mass. Amongst other substrates, mTORC1 phosph…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345305", "date": "2026-03-19", "published_at": "2026-03-19T14:00:00Z", "sentiment": { "label": "positive", "score": 0.45, "confidence": 0.45 } }, { "source": "news", "source_name": "BBC News", "title": "Fit-again Faletau back for Cardiff at rivals Bulls", "description": "Taulupe Faletau returns to the Cardiff matchday squad for the first time since New Year's Day against Bulls in the URC.", "url": "https://www.bbc.com/sport/rugby-union/articles/ce828nejelyo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-03-19", "published_at": "2026-03-19T12:32:10Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "Fit-again Faletau back for Cardiff at rivals Bulls", "description": "Taulupe Faletau returns to the Cardiff matchday squad for the first time since New Year's Day against Bulls in the URC.", "url": "https://www.bbc.com/sport/rugby-union/articles/ce828nejelyo", "date": "2026-03-19", "published_at": "2026-03-19T12:32:05Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Degradation of G-quadruplex-binding proteins in chromatin using G4-ligand-based proteolysis-targeting chimeras", "description": "DNA G-quadruplex (G4) structures can form at regulatory regions of transcriptionally active genes in open chromatin and are abundant in cancer states, but targeting G4-binding proteins in their native chromatin environment is challenging. Now bifunctional mol…", "url": "https://www.nature.com/articles/s41557-026-02111-y", "date": "2026-03-19", "published_at": "2026-03-19T00:00:00Z", "sentiment": { "label": "negative", "score": -0.285, "confidence": 0.28 } }, { "source": "news", "source_name": "Nature.com", "title": "Liquid biopsy for the diagnosis of EBV-positive Burkitt’s lymphoma in endemic areas", "description": "In clinical validation of a liquid biopsy assay, the approach enabled fast and accurate molecular diagnosis of EBV+ Burkitt’s lymphoma in more than 200 children and young adults in Tanzania and Uganda.", "url": "https://www.nature.com/articles/s41591-026-04291-z", "date": "2026-03-19", "published_at": "2026-03-19T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "The Irish Times", "title": "Morris foul tackle on Ulster’s Izuchukwu should have been straight red card", "description": "The incident in question took place in the 64th minute of Ulster’s victory at the Hive last weekend", "url": "https://www.irishtimes.com/sport/rugby/2026/03/18/morris-foul-tackle-on-ulsters-izuchukwu-should-have-been-straight-red-card/", "date": "2026-03-18", "published_at": "2026-03-18T21:52:24Z", "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "Plos.org", "title": "Plagl1 regulates the retinal progenitor cell to Müller glial cell transition", "description": "Author summary As the only glial cells in the retina, Müller glia play an essential role in maintaining tissue homeostasis and supporting retinal integrity and function. During development, Müller glia are derived from multipotent RPCs, which also give rise t…", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012020", "date": "2026-03-18", "published_at": "2026-03-18T14:00:00Z", "sentiment": { "label": "positive", "score": 0.784, "confidence": 0.78 } }, { "source": "news", "source_name": "Plos.org", "title": "Mutual solubilization of rosiglitazone and ibuprofen: Investigation and mechanistic insight", "description": "Purpose We report for the first time that co-dissolved rosiglitazone and ibuprofen mutually enhance their aqueous solubility; the study was designed to quantify this phenomenon and clarify its origin. Methods Solubility was measured by HPLC. Fluorescence an…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345185", "date": "2026-03-18", "published_at": "2026-03-18T14:00:00Z", "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Banzai to Host Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time", "description": "Banzai to Host Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time...", "url": "https://www.globenewswire.com/news-release/2026/03/18/3258172/0/en/Banzai-to-Host-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-Conference-Call-on-Tuesday-March-31-2026-at-4-30-p-m-Eastern-Time.html", "date": "2026-03-18", "published_at": "2026-03-18T12:31:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Tomdispatch.com", "title": "Another Thing Trump and Epstein Share: White Supremacy", "description": "Jeffrey Epstein was not only a rapist and a child predator, but also—wait for it—a white supremacist. While some speculate that the Epstein issue is just a distraction from President Donald Trump’s virulent and endless racism, others feel that the video the p…", "url": "https://tomdispatch.com/donald-trumps-racism-mirrors-jeffrey-epsteins/", "date": "2026-03-18", "published_at": "2026-03-18T12:19:06Z", "sentiment": { "label": "negative", "score": -0.904, "confidence": 0.9 } }, { "source": "pubmed", "pmid": "41903301", "title": "Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).", "authors": "Kanemura H et al.", "journal": "European journal of cancer (Oxford, England : 1990)", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41903301/", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "pubmed", "pmid": "41903103", "title": "Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Thailand: Epidemiological Data Update.", "authors": "Thakkar K et al.", "journal": "Pulmonary therapy", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41903103/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41898871", "title": "Internal Validation of a Mitochondrial DNA Control Region Sequencing Workflow Using Precision ID mtDNA Whole Genome Panel, Ion Chef™ System and Ion S5™ XL System.", "authors": "Shue BH et al.", "journal": "Genes", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41898871/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41898311", "title": "Integration of RNA Editing into Multiomics Machine Learning Models for Predicting Drug Responses in Breast Cancer Patients.", "authors": "Bernal YA et al.", "journal": "Biomedicines", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41898311/", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "pubmed", "pmid": "41896400", "title": "Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.", "authors": "Meeraus W et al.", "journal": "Infectious diseases and therapy", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41896400/", "sentiment": { "label": "negative", "score": -0.67, "confidence": 0.67 } }, { "source": "pubmed", "pmid": "41895568", "title": "Accumulation Patterns of Polychlorinated Alkanes in an Arctic Marine Food Web.", "authors": "Giebichenstein J et al.", "journal": "Environmental research", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41895568/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41887965", "title": "Influence of computed tomography reconstruction algorithms on coronary artery calcium scores and reader agreement.", "authors": "Yang LD et al.", "journal": "Journal of cardiovascular computed tomography", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41887965/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41887157", "title": "Corrigendum to \"Systemic distribution and transplacental transfer of micro- and nanoplastics in a filter-feeding marine predator\" [Environ. Res. Volume 298, 1 June 2026, 124237].", "authors": "Ruiz-Sagalés M et al.", "journal": "Environmental research", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41887157/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41886673", "title": "Oral nutritional interventions in hospitalised older people at nutritional risk: a network meta-analysis of individual participant data.", "authors": "Kiesswetter E et al.", "journal": "The Cochrane database of systematic reviews", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41886673/", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41884877", "title": "Combined Nutritional and Exercise Interventions for Cachexia in Chronic Diseases: A Systematic Review and Meta-analysis Limited to Cancer Cachexia.", "authors": "Okamura M et al.", "journal": "Progress in rehabilitation medicine", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41884877/", "sentiment": { "label": "negative", "score": -0.743, "confidence": 0.74 } }, { "source": "pubmed", "pmid": "41883204", "title": "Delonix regia flower extract protects against diabetic cardiac remodeling via modulating eNOS/NO/cGMP and NF-κB/iNOS/TNF-α trajectories.", "authors": "Hassan N et al.", "journal": "The Journal of pharmacy and pharmacology", "date": "2026 Mar 5", "url": "https://pubmed.ncbi.nlm.nih.gov/41883204/", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "pubmed", "pmid": "41882535", "title": "Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests.", "authors": "Sartini C et al.", "journal": "BMC gastroenterology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41882535/", "sentiment": { "label": "negative", "score": -0.612, "confidence": 0.61 } }, { "source": "pubmed", "pmid": "41882365", "title": "Electrochemical corrosion accompanies dendrite growth in solid electrolytes.", "authors": "Fincher CD et al.", "journal": "Nature", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41882365/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41880124", "title": "Development of the Patient Satisfaction with Medication for Diabetes (PSMD) questionnaire.", "authors": "Boye KS et al.", "journal": "Journal of patient-reported outcomes", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41880124/", "sentiment": { "label": "positive", "score": 0.44, "confidence": 0.44 } }, { "source": "pubmed", "pmid": "41879365", "title": "Giant Magnetostriction in Ferrimagnetic SmFe(5)As(3).", "authors": "Karychort O et al.", "journal": "Angewandte Chemie (International ed. in English)", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41879365/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41878748", "title": "Characteristics of Adult Severe Uncontrolled Asthma Patients in Primary Care and Modifications in Prescribed Inhalation Treatments.", "authors": "Konradsen JR et al.", "journal": "Journal of asthma and allergy", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41878748/", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "pubmed", "pmid": "41876063", "title": "Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities.", "authors": "McCann WA et al.", "journal": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41876063/", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41875590", "title": "Multi-laboratory development of bioanalytical methods for two cyclic peptides, cyclorasin9A5 and 3003pep.", "authors": "Ishikawa R et al.", "journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41875590/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41874648", "title": "Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV).", "authors": "Mollica V et al.", "journal": "Cancer immunology, immunotherapy : CII", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41874648/", "sentiment": { "label": "positive", "score": 0.25, "confidence": 0.25 } }, { "source": "pubmed", "pmid": "41870027", "title": "Automated Online Direct mRNA Sequence Mapping Using Partial RNase T1 Digests.", "authors": "Dale JS et al.", "journal": "Analytical chemistry", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41870027/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41870025", "title": "Molecular Probes for Sulfatase Detection and Bio-Imaging.", "authors": "Cheekatla SR et al.", "journal": "Chembiochem : a European journal of chemical biology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41870025/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41865189", "title": "Low-resolution FAIMS for increased peptide coverage in low-load and single-cell proteomics.", "authors": "Hoch DG et al.", "journal": "Scientific reports", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41865189/", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41864206", "title": "The E3-ome gene-centric compendium reveals the human E3 ligase landscape.", "authors": "Chua NK et al.", "journal": "Cell", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41864206/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41859043", "title": "Clinically aggressive early-onset pancreatic ductal adenocarcinoma with KRAS wild-type status: A case report.", "authors": "Avendaño ME et al.", "journal": "Biomedical reports", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41859043/", "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "pubmed", "pmid": "41857718", "title": "-Impact of first-trimester preeclampsia screening on perinatal and maternal morbidity: the RANSPRE open multicenter randomized trial.", "authors": "Tsatsaris V et al.", "journal": "BMC pregnancy and childbirth", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41857718/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41857682", "title": "Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.", "authors": "Musallam KM et al.", "journal": "European journal of haematology", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41857682/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41850747", "title": "Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.", "authors": "Fordham AM et al.", "journal": "Molecular cancer therapeutics", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41850747/", "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "pubmed", "pmid": "41849846", "title": "Diagnostic performance of somatostatin receptor positron emission tomography in preoperative evaluation of pancreatic neuroendocrine tumor lymph node metastases.", "authors": "Gudmundsdottir H et al.", "journal": "Surgery", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41849846/", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "pubmed", "pmid": "41847855", "title": "CD5L:p40, a novel heterodimeric regulator of type 2 inflammation.", "authors": "Wang C et al.", "journal": "Journal of immunology (Baltimore, Md. : 1950)", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41847855/", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "pubmed", "pmid": "41846680", "title": "Gestational age amplifies the risk of airflow obstruction in adult smokers with asthma.", "authors": "Konradsen JR et al.", "journal": "ERJ open research", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41846680/", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41844540", "title": "Reducing Hospital Readmissions for Injection Drug Use-Related Infections: A Rapid Qualitative Analysis of Health Care Teams' Consultations to Inform Intervention Design.", "authors": "Key S et al.", "journal": "Journal of addiction medicine", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41844540/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41843665", "title": "Nudibranch color diversity shares a common physical basis in guanine photonic structure 'pixels'.", "authors": "Humphrey S et al.", "journal": "Proceedings of the National Academy of Sciences of the United States of America", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41843665/", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "pubmed", "pmid": "41843174", "title": "Human CD3 complex is required for the generation of T-cell receptor-like chimeric antigen receptor targeting WT1 in natural killer cells.", "authors": "Luanpitpong S et al.", "journal": "Cancer immunology, immunotherapy : CII", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41843174/", "sentiment": { "label": "negative", "score": -0.421, "confidence": 0.42 } }, { "source": "pubmed", "pmid": "41843011", "title": "Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study.", "authors": "Kulthanan K et al.", "journal": "American journal of clinical dermatology", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41843011/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41827732", "title": "Long-Term Oncological Outcomes of Minimally Invasive Surgery in Non-Small Cell Lung Cancer: An Updated Review.", "authors": "Delcuratolo MD et al.", "journal": "Cancers", "date": "2026 Feb 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41827732/", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "pubmed", "pmid": "41825348", "title": "High-sensitivity MAM to support early-stage activities during biotherapeutic development.", "authors": "Millán-Martín S et al.", "journal": "Journal of chromatography. A", "date": "2026 May 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41825348/", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "41824798", "title": "Contextual High-Throughput 3D Volume Electron Microscopy Data Acquisition Using Artificial Intelligence.", "authors": "Hurník Konečná T et al.", "journal": "Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41824798/", "sentiment": { "label": "positive", "score": 0.677, "confidence": 0.68 } }, { "source": "pubmed", "pmid": "41820745", "title": "Podcast: Adherence to Injectables.", "authors": "Sánchez J", "journal": "Dermatology and therapy", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41820745/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41814618", "title": "Poppy seed anaphylaxis: clinical and allergic features.", "authors": "Novembre E et al.", "journal": "Allergologia et immunopathologia", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41814618/", "sentiment": { "label": "negative", "score": -0.296, "confidence": 0.3 } }, { "source": "pubmed", "pmid": "41812769", "title": "Muscle movement and metabolism: exercise and skeletal muscle as mediators of health-a report from the 26th Annual Harvard Nutrition Obesity Symposium, 2025.", "authors": "Carollo L et al.", "journal": "The American journal of clinical nutrition", "date": "2026 Mar 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41812769/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41812750", "title": "Systemic distribution and transplacental transfer of micro- and nanoplastics in a filter-feeding marine predator.", "authors": "Ruiz-Sagalés M et al.", "journal": "Environmental research", "date": "2026 Mar 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41812750/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41811753", "title": "EIQuan: A Stacked Ensemble Learning-Based Predictor for Quantification of Nontargeted Chemicals in Gas Chromatography Coupled with Electron Ionization High-Resolution Mass Spectrometry Analysis.", "authors": "Liu Y et al.", "journal": "Environmental science & technology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41811753/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41806905", "title": "Pathology in motion: Automation from specimen to report.", "authors": "L'Imperio V et al.", "journal": "Critical reviews in oncology/hematology", "date": "2026 Mar 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41806905/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41806102", "title": "Identification of intranasal oxytocin plasma proteome signatures.", "authors": "Breithaupt L et al.", "journal": "Endocrine", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41806102/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41801661", "title": "Challenges in Conducting Quantitative Patient-Centered Benefit-Risk Assessments: A Case Study in Ph + ALL with Immature Efficacy Data.", "authors": "Ashaye A et al.", "journal": "Therapeutic innovation & regulatory science", "date": "2026 Mar 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41801661/", "sentiment": { "label": "positive", "score": 0.077, "confidence": 0.08 } }, { "source": "pubmed", "pmid": "41798765", "title": "Non-syndromic hyper-IgE in children: A practical approach.", "authors": "Castagnoli R et al.", "journal": "The World Allergy Organization journal", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41798765/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41794910", "title": "A Conceptual Disease Model of Symptoms and Impacts in Adults with Prurigo Nodularis: A Qualitative and Literature-Informed Study.", "authors": "Kwatra SG et al.", "journal": "Dermatology and therapy", "date": "2026-03-30", "url": "https://pubmed.ncbi.nlm.nih.gov/41794910/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41793578", "title": "Patients' Experiences of Obstructive Sleep Apnea and Tirzepatide Treatment: An Exit Interview Study.", "authors": "Shinde S et al.", "journal": "The patient", "date": "2026 Mar 7", "url": "https://pubmed.ncbi.nlm.nih.gov/41793578/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41793572", "title": "A Meta-analysis Investigating Response Rates with Continuous Bruton Tyrosine Kinase Inhibitor Monotherapies in the Treatment of B Cell Lymphomas.", "authors": "Zinzani PL et al.", "journal": "Oncology and therapy", "date": "2026 Mar 7", "url": "https://pubmed.ncbi.nlm.nih.gov/41793572/", "sentiment": { "label": "negative", "score": -0.077, "confidence": 0.08 } }, { "source": "pubmed", "pmid": "41792598", "title": "Diagnostic accuracy of chip hybridization from formalin-fixed paraffin embedded bioptic specimens in a cohort with predominantly extrapulmonary mycobacterial disease.", "authors": "Winkelmann R et al.", "journal": "BMC microbiology", "date": "2026 Mar 7", "url": "https://pubmed.ncbi.nlm.nih.gov/41792598/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "edgar_news", "title": "Thermo Fisher Scientific Inc.", "text": "Thermo Fisher Scientific completed the acquisition of Clario Holdings for $8.875B, enhancing its position as a partner for pharma and biotech clients. Clario's solutions will become part of Thermo Fisher's Laboratory Products and Biopharma Services segment. The acquisition is expected to contribute $0.45 of adjusted earnings per share in the first year.\n\n*Thermo Fisher Scientific Inc. [TMO](https://www.google.com/finance/quote/TMO:NYSE) is headquartered in Waltham, MA.*\n\n[Source](https://www.sec", "author": "edgar_news_01", "score": 1, "num_comments": 0, "date": "2026-03-24", "url": "https://reddit.com/r/edgar_news/comments/1s2chdn/thermo_fisher_scientific_inc/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "BioTechHealthX", "title": "Here’s What Makes Thermo Fisher Scientific (TMO) a Smart Investment Pick", "text": "", "author": "BioTechHealthX", "score": 1, "num_comments": 0, "date": "2026-03-21", "url": "https://reddit.com/r/BioTechHealthX/comments/1rzhfeu/heres_what_makes_thermo_fisher_scientific_tmo_a/", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "reddit", "subreddit": "trading212", "title": "МYNZ already tied to Thermo Fisher, Quest, and Liquid for U.S. execution", "text": "For a microcap, Mainz Biomed is unusually well connected in the U.S.\n\n\n\nМYNZ has reported 100% sensitivity and about 95% specificity in its pancreatic feasibility study. But beyond the data, look at the infrastructure already in place.\n\n\n\nThermo Fisher Scientific, a major U.S. life sciences company listed under TMO, is collaborating with Mainz on its next generation colorectal test. Thermo brings assay platforms, automation, and manufacturing scale that can accelerate development and regulatory ", "author": "JellyTundraX", "score": 0, "num_comments": 1, "date": "2026-03-03", "url": "https://reddit.com/r/trading212/comments/1rjz1qy/мynz_already_tied_to_thermo_fisher_quest_and/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "Pennystocksv2", "title": "MYNZ already plugged into Thermo Fisher, Quest and AI partners for U.S. scale", "text": "A lot of small biotechs talk about U.S. expansion. Fewer are already working with major U.S. infrastructure players.\n\n\n\nMainz Biomed, ticker MYNZ, is not building its U.S. strategy alone. Alongside reporting 100% sensitivity and about 95% specificity in its pancreatic feasibility study, the company has put real partnerships in place that support scaling and regulatory progress.\n\n\n\nStart with Thermo Fisher Scientific, a major U.S. life sciences company listed on NYSE under TMO. Mainz is collabora", "author": "Loose-Nature-2308", "score": 1, "num_comments": 0, "date": "2026-03-03", "url": "https://reddit.com/r/Pennystocksv2/comments/1rjyaj9/mynz_already_plugged_into_thermo_fisher_quest_and/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "investing", "title": "Just getting into investments - Started with Paper trading/Paper investing", "text": "As the title suggests, I have made some paper investments on investopedia simulator a couple months back and haven't seen any progress. Though the value fluctuates up and down, over the long run it has stayed around the same amount. I wanted to know what I was doing wrong, what i was doing right and what must I do to improve. \n\nI'm not committed to looking at charts everyday, though I try to keep myself updated with industry trends and how the market is generally looking like. \n\nI am attaching a", "author": "Ok_Tear5594", "score": 0, "num_comments": 12, "date": "2026-03-02", "url": "https://reddit.com/r/investing/comments/1rix96b/just_getting_into_investments_started_with_paper/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "investingforbeginners", "title": "Top Oversold/Overbought Stocks - March 17, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [GEGGL](https://marketrodeo.com/asset/GEGG", "author": "MarketRodeo", "score": 0, "num_comments": 4, "date": "2026-03-17", "url": "https://reddit.com/r/investingforbeginners/comments/1rw3mxr/top_oversoldoverbought_stocks_march_17_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "marketrodeo", "title": "Top Oversold/Overbought Stocks - March 17, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [GEGGL](https://marketrodeo.com/asset/GEGG", "author": "MarketRodeo", "score": 6, "num_comments": 2, "date": "2026-03-17", "url": "https://reddit.com/r/marketrodeo/comments/1rw3mw7/top_oversoldoverbought_stocks_march_17_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "marketrodeo", "title": "Top Oversold/Overbought Stocks - March 19, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [V](https://marketrodeo.com/asset/V) | Vis", "author": "MarketRodeo", "score": 10, "num_comments": 1, "date": "2026-03-19", "url": "https://reddit.com/r/marketrodeo/comments/1rxxm00/top_oversoldoverbought_stocks_march_19_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "marketrodeo", "title": "Top Oversold/Overbought Stocks - March 18, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [TMO](https://marketrodeo.com/asset/TMO) |", "author": "MarketRodeo", "score": 6, "num_comments": 1, "date": "2026-03-18", "url": "https://reddit.com/r/marketrodeo/comments/1rx110t/top_oversoldoverbought_stocks_march_18_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "marketrodeo", "title": "Top Oversold/Overbought Stocks - March 13, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [HD](https://marketrodeo.com/asset/HD) | T", "author": "MarketRodeo", "score": 9, "num_comments": 1, "date": "2026-03-13", "url": "https://reddit.com/r/marketrodeo/comments/1rski6o/top_oversoldoverbought_stocks_march_13_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "DeepFuckingValue", "title": "Top Oversold/Overbought Stocks - March 17, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [GEGGL](https://marketrodeo.com/asset/GEGG", "author": "MarketRodeo", "score": 1, "num_comments": 1, "date": "2026-03-17", "url": "https://reddit.com/r/DeepFuckingValue/comments/1rw3mze/top_oversoldoverbought_stocks_march_17_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "investingforbeginners", "title": "Top Oversold/Overbought Stocks - March 13, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [HD](https://marketrodeo.com/asset/HD) | T", "author": "MarketRodeo", "score": 3, "num_comments": 1, "date": "2026-03-13", "url": "https://reddit.com/r/investingforbeginners/comments/1rski7t/top_oversoldoverbought_stocks_march_13_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "DeepFuckingValue", "title": "Top Oversold/Overbought Stocks - March 19, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [V](https://marketrodeo.com/asset/V) | Vis", "author": "MarketRodeo", "score": 2, "num_comments": 0, "date": "2026-03-19", "url": "https://reddit.com/r/DeepFuckingValue/comments/1rxxm2x/top_oversoldoverbought_stocks_march_19_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "DeepFuckingValue", "title": "Top Oversold/Overbought Stocks - March 18, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [TMO](https://marketrodeo.com/asset/TMO) |", "author": "MarketRodeo", "score": 3, "num_comments": 0, "date": "2026-03-18", "url": "https://reddit.com/r/DeepFuckingValue/comments/1rx1142/top_oversoldoverbought_stocks_march_18_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "DeepFuckingValue", "title": "Top Oversold/Overbought Stocks - March 13, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [HD](https://marketrodeo.com/asset/HD) | T", "author": "MarketRodeo", "score": 8, "num_comments": 0, "date": "2026-03-13", "url": "https://reddit.com/r/DeepFuckingValue/comments/1rski99/top_oversoldoverbought_stocks_march_13_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "investingforbeginners", "title": "Top Oversold/Overbought Stocks - March 19, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [V](https://marketrodeo.com/asset/V) | Vis", "author": "MarketRodeo", "score": 1, "num_comments": 0, "date": "2026-03-19", "url": "https://reddit.com/r/investingforbeginners/comments/1rxxm1a/top_oversoldoverbought_stocks_march_19_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "investingforbeginners", "title": "Top Oversold/Overbought Stocks - March 18, 2026 📊", "text": "The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.\n\n## 📉 **Oversold Stocks:**\n\nStocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.\n\n| Symbol | Company | RSI | Price | Change | %Change | Market Cap |\n|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|\n| [TMO](https://marketrodeo.com/asset/TMO) |", "author": "MarketRodeo", "score": 0, "num_comments": 0, "date": "2026-03-18", "url": "https://reddit.com/r/investingforbeginners/comments/1rx112c/top_oversoldoverbought_stocks_march_18_2026/", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "GreenWicks", "title": "Late-night stock scanning led me to this tiny cancer diagnostics company", "text": "Last weekend I was doing the usual - scrolling through small-cap stocks under $1, trying to see which ones actually have something real behind them. Not hype, not shells, but companies with real tech or real markets.\n\nThat’s how I ended up diving into MYNZ.\n\nAt first glance, it was just another ticker around $0.90, but the 52-week range from $0.55 to $5.62 immediately told me this stock can move. That’s always a signal that the market reacts when there’s news or data.\n\nThen I opened their invest", "author": "Carlene_Trammel", "score": 2, "num_comments": 1, "date": "2026-03-06", "url": "https://reddit.com/r/GreenWicks/comments/1rmetq8/latenight_stock_scanning_led_me_to_this_tiny/", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "reddit", "subreddit": "ChartNavigators", "title": "What plays are you looking into for tomorrow", "text": "[Sectors](https://www.sectorspdrs.com/)\n\n[Fed Calendar](https://www.federalreserve.gov/newsevents/calendar.htm)\n\n[Investing.com](https://www.investing.com/)\n\n\n\n\n\nUptrending Tickers\n\n\n\n\nRecommended Price Range: $120–$131\nArm Holdings plc (ARM) — 3/6/26 140.0C @ 1.22\nRecent Insights: Fundamental strength and technical momentum supporting trend continuation.\nAnalyst Consensus: Buy\nPrice Target: $132.9–$162.5\n\n\n\nRecommended Price Range: $116–$126\nMerck & Co., Inc. (MRK) — 3/6/26 127.0C @ 1.08\nRecent", "author": "Badboyardie", "score": 1, "num_comments": 1, "date": "2026-03-02", "url": "https://reddit.com/r/ChartNavigators/comments/1rif4xq/what_plays_are_you_looking_into_for_tomorrow/", "sentiment": { "label": "positive", "score": 0.25, "confidence": 0.25 } }, { "source": "reddit", "subreddit": "biotech", "title": "President Trump visits Thermo Fisher", "text": "As a former employee myself, I always had a hunch that Marc Casper was in cahoots with the current US POTUS, especially after I saw coal refinery equipment ads on the homepage. What are everyone’s thoughts?", "author": "missprincesscarolyn", "score": 176, "num_comments": 50, "date": "2026-03-14", "url": "https://reddit.com/r/biotech/comments/1rtff1h/president_trump_visits_thermo_fisher/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "labrats", "title": "The Lab of Curiosity -1000 pieces from Thermo Fisher Scientific", "text": "", "author": "K8K8K8K9", "score": 519, "num_comments": 13, "date": "2026-03-29", "url": "https://reddit.com/r/labrats/comments/1s6xij6/the_lab_of_curiosity_1000_pieces_from_thermo/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "Jigsawpuzzles", "title": "The Lab of Curiosity -1000 pieces from Thermo Fisher Scientific", "text": "This was super fun with all the crazy images and scenes. Easy and enjoyable. Nice fitting pieces ", "author": "K8K8K8K9", "score": 286, "num_comments": 14, "date": "2026-03-29", "url": "https://reddit.com/r/Jigsawpuzzles/comments/1s6xi2d/the_lab_of_curiosity_1000_pieces_from_thermo/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "PharmacyPH", "title": "pls give company reviews about Thermo Fisher Scientific BGC. culture, salary, workload, management etc", "text": "need help!! worth it ba sa company na 'to? 🙏 I’m a\n\nRegistered Pharmacist, applied for Medical Information Specialist 1 role.\n\nso far, ang bilis ng hiring process ko. i just applied march 10. got contacted march 11. done phone screening march 13. then for Berlitz assessment agad this march 16.\n\nthank you sa sasagot!! 😇", "author": "Big_Restaurant2082", "score": 16, "num_comments": 46, "date": "2026-03-13", "url": "https://reddit.com/r/PharmacyPH/comments/1rsif15/pls_give_company_reviews_about_thermo_fisher/", "sentiment": { "label": "positive", "score": 0.077, "confidence": 0.08 } }, { "source": "reddit", "subreddit": "massspectrometry", "title": "ThermoFisher Vanquish HPLC Issue", "text": "Hi all,\n\nI encountered two issues while operating the ThermoFisher Vanquish HPLC today and would appreciate your assistance:\n\n1. System Leak: The column pressure dropped suddenly from \\~400 bar to \\~60 bar. I identified a leak at the bottom of the column (see attached photo). I attempted to resolve this by re-tightening the fittings, but the leak persist despite setting the flow rate low from the typical flow rate. FYI, our flow direction is bottom to top. \n\n2. Software and Hardware Malfunctio", "author": "just4fun420blazeit", "score": 12, "num_comments": 28, "date": "2026-03-19", "url": "https://reddit.com/r/massspectrometry/comments/1ry38kt/thermofisher_vanquish_hplc_issue/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } } ] } }